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Chapter overview 
Chapter 1  Introduction 
This chapter described the context of this research; why rectal cancer 
treatment is challenging; impact of multidisciplinary treatment on the 
outcomes.  
Chapter 2  Overview in colorectal cancer treatment  
To review of role of various treatment modalities and variations to 
optimise both short-term and long-term outcomes;  
 Hiranyakas A, Yik Hong H. Surgical Treatment of Colorectal 
Cancer – a Review. Int Surg. 2011; 96(2):120-6. 
Chapter 3  Laparoscopic surgery for rectal cancer 
To discuss and propose appropriate laparoscopic techniques / 
approaches in the challenging surgical conditions to achieve the best 
possible outcomes;  
 Hiranyakas A, Yik Hong H. Laparoscopic Ultralow Anterior 
Resection Versus Laparoscopic Pull-through with Coloanal 
Anastomosis for Rectal Cancers – a Comparative Study. Am J 
Surg. 2011; 202(3):291-7. 
Chapter 4  Factors influencing rectal cancer treatment outcomes 
To discuss and propose the factors influencing the optimal outcomes for 
rectal cancer treatment;  
 Hiranyakas A, Yik-Hong H, da Silva, GM, Wexner SD, Allende D, 
Berho M. Factors Influencing Circumferential Resection Margin in 
Rectal Cancer. Colorectal Dis. 2013 ;15(3):298-303. 
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Chapter 5 Technique to avoid postsurgical complication 
To discuss and propose surgical techniques essential in avoiding 
serious postsurgical consequences;  
 Hiranyakas A, da Silva GM, Denoya P, Shawki S, Wexner SD. 
Colorectal Anastomotic Stricture: Is it associated with inadequate 
Colonic Mobilization? Tech Coloproctol. 2013 ;17(4):371-5. 
Chapter 6  Protocols for rapid recovery 
To discuss in depth for the appropriate immediate postsurgical-care 
protocals to achieve the smooth and rapid recovery (among the most 
common diseased population);  
 Hiranyakas A, Bashankaev B, Seo CJ, Khaikin M, Wexner SD. 
Epidemiology,    Pathophysiology and Medical Management of 
Postoperative Ileus in the Elderly. Drugs Aging. 2011; 28(2):107-
18.  
Chapter 7 Closure of the ileostomy 
To discuss and propose the necessity of certain surgical procedures to 
enhance optimal immediate postsurgical outcomes in low rectal cancer 
patients;  
 Hiranyakas A, Rather A, da Sliva GM, Wexner SD, Weiss EG. 
Loop ileostomy Closure after Laparoscopic vs. Open Surgery: Is 
There a Difference? Surg Endosc. 2013 ;27(1):90-4.  
Chapter 8 Treatment of common stomal complication 
To discuss and propose minimally invasive surgical approaches in the 
treatment of the common stomal consequence;  
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 Hiranyakas A, Yik Hong H. Laparoscopic Parastoma Hernia 
Repair, Multi-media Article. Dis Colon Rectum 2010; 53(9):1334-6. 
 
Chapter 9 Conclusion, outcomes and future research directions   
This chapter gives the conclusions from the studies and proposes future 
research directions.  
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versus laparoscopic pull-through with coloanal anastomosis for rectal 
cancers. All the published studies involved in each chapter of the thesis 
were carefully illustrated in their original format with my great respect to 
the international peer-review. Nevertheless, each chapter contained the 
overview aiming to state the connectivity of the ideas for each specific 
detail contained in each chapter. Despite the fact that the majority of the 
studies were conducted in high-volume, specialized centers, it was a 
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Chapter 1: Introduction 
 
       Cancer is one of the leading causes of death throughout the world. Colorectal cancer is 
currently one of the major causes of cancer-related death, especially in the developed 
countries. The incidence of colorectal cancer has also been found to be increasing in 
developing countries. 
        Even though a multidisciplinary approach is the best treatment modality for colorectal 
cancer patients, surgery is still the mainstay for curative colorectal cancer treatment. 
Colorectal cancer surgery has been developed for decades, but a new paradigm in 
colorectal cancer surgery in term of laparoscopic technique emerged approximately 25 years 
ago. The first laparoscopic colon resection was reported in 1991 (1). This procedure 
presented doubts about adversely affecting the chance of cure for colorectal cancer. 
Randomized trials have been carefully performed to compare the traditional open surgery 
with the laparoscopic technique. These studies   examined and compared surgical 
specimens, differences in lymph node harvest and bowel margins. In addition, rates of 
recurrence and overall survival were also compared. In “The clinical outcome of surgical 
therapy (COST) study group trial”, there was no difference in median length of bowel 
margins. Results of nonrandomized trials in 1990s did not detect differences in survival 
between patients undergoing laparoscopic and open resection. In a single-center trial, 
published in 2002, Lacy et al. reported an increase in disease-free survival in their 
laparoscopic arm (2). These results were thought to be related to less metabolic insult on the 
immune system with a laparoscopic technique, but have not been reproduced. Thus it has 
been proven that recurrence and survival rate is not compromised by the use of a 
laparoscopic approach. 
        Several trials which compared laparoscopic and open surgery have also found small 
but measurable differences in postoperative pain, return of bowel function, and length of 
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hospital stay (3). Three large randomized trials have found no differences in operative 
mortality between the two groups (4-6). Laparoscopic surgery for colon cancer is currently 
considered a well-accepted alternative to open resection for colon cancer. 
        Rectal cancer is one of the most difficult management challenges in colorectal surgery. 
As a result, laparoscopic rectal cancer surgery is much less developed and the results 
therefore not as certain. For rectal cancer, differences in anatomy, and natural history of 
disease compared to colon cancer have led to a unique surgical approach and outcome 
measurement. Total mesorectal excision (TME) has become the surgical treatment of choice 
for rectal cancer (7). This is a technique which achieves complete resection of the rectum 
together with its draining lymphatics, along well-defined surgical anatomical planes which 
results in low rates of cancer recurrence. Prior to the TME era, local recurrence rates of 
≥20% were commonly reported.  Heald and Ryall showed, through a variety of publications, 
that local recurrence rates could be decreased to ≤ 5% with TME. More importantly, his 
concepts could be taught, adopted, and utilized, and similar improvements in local 
recurrence rates and survival statistics could be achieved (8). Quirke and colleagues also 
demonstrated that the survival improvements were a result of removing the rectum and the 
mesorectum as an intact envelope of tissue. This would achieve a negative circumferential 
resection margin. He also showed that the local recurrence rates of 85% were found in 
patients who had positive circumferential resection margins in comparison with 3% 
recurrence rates in patients in whom the radial margins were tumor free (9). Meticulous 
dissection with careful attention to anatomy and embryologic tissue planes were essential 
toward a good local control of the disease (10). 
      Although a difficult technique to master, laparoscopy allows very good exposure of the 
pelvic cavity because of magnification and seems to facilitate pelvic dissection. Laparoscopy 
for rectal cancer offers several advantages in compared to open surgery, including 
postoperative pain, shorter duration of ileus, shorter hospital stay, and less disability (11-15). 
However, these advantages of laparoscopic TME are beneficial to patients only when the 
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oncologic cure rate for this technique is at least similar to that of open TME. Several trials 
found that the oncologic resection using laparoscopic TME is feasible, adequate, and can be 
as efficacious as open resection (16-18). The CLASICC trial had noticed an increase in 
circumferential radial margin positivity in the low anterior laparoscopic resection group. The 
trial had only a small subset of patients with rectal cancer. However, long-term follow-up 
which was reported in 2013 suggested that long-term local and distant recurrence for rectal 
cancer treated laparoscopically was comparable to open treatment (19). The COREAN trial 
compared laparoscopic and open resection of 340 neoadjuvant treated patients with stage II 
and III mid to low rectal cancer. The early, reported in 2010, showed no difference in short-
term outcomes and quality of the oncologic resection (circumferential radial margin, total 
mesorectal excision completeness, lymph node evaluation, and complication rate). Their 
recent (2014) report of long-term follow-up also showed no difference in long-term outcome 
(20, 21). The Colorectal Cancer Laparoscopic or Open Resection II (COLOR II) trial (22) 
included 1044 patients with stage I to II rectal cancer within 15 cm of the anal verge, 
randomized 2:1 laparoscopic to open resection. Neoadjuvant therapy was used in only 59% 
of patients. Pathologic complete response occurred in 8% to 10% of patients. Total 
mesorectal excision completeness was 92% in laparoscopic-surgery group and 94% in 
open-surgery group. Distal margin results were all negative. The circumferential radial 
margin positivity was found in 10% for both laparoscopic and open-surgery group. The 
circumferential radial margin positivity rate in the low rectum open arm was 22% and only 
9% in the laparoscopic arm. Three-year local recurrence was 5%. Disease-free survival 
rates were 74.8% in the laparoscopic-surgery group and 70.8% in the open-surgery group. 
Overall survival rates were 86.7% in the laparoscopic-surgery group and 83.6% in the open-
surgery group. The conclusion is that laparoscopic resection of rectal cancer is safe and 
feasible (23). 
      Interestingly, ACOSOG Z6051 Randomized Clinical Trial (24) aiming to determine if 
laparoscopic resection is noninferior to open resection for clinical stage II or III rectal cancer 
17 
 
within 12 cm of the anal verge. The multicenter study of 35 institutions in the United States 
and Canada was reported in 2015. This trial included the group of highly motivated, 
credentialed, expert laparoscopic rectal surgeons. Two hundred and forty with laparoscopic 
resection and 222 with open resection were evaluable for analysis of the 486 enrolled 
patients. All patients underwent neoadjuvant therapy. The study reported successful 
resection in 81.7% of laparoscopic resection cases (95%CI, 76.8%–86.6%) and 86.9%of 
open resection cases (95%CI, 82.5%–91.4%).  Conversion to open resection was 11.3%. 
They also found that the operative time was significantly longer for laparoscopic resection 
(mean, 266.2 vs 220.6 minutes; mean difference, 45.5 minutes; 95%CI, 27.7–63.4; P < 
.001). The length of stay, readmission within 30 days and severe complications did not differ 
significantly. Quality of the total mesorectal excision specimen in 462 operated and analyzed 
surgeries was complete (77%) and nearly complete (16.5%) in 93.5% of the cases. Negative 
circumferential radial margin was observed in 90% of the overall group (87.9% laparoscopic 
resection and 92.3% open resection; p = 0.11). Distal margin result was negative in more 
than 98% of patients irrespective of type of surgery (p = 0.91). Nevertheless, after the 
calculation for inferiority (primary end points of circumferential radial margin results negative, 
distal margin results negative, and total mesorectal excision complete or nearly complete), 
the authors concluded that the use of laparoscopic resection compared with open resection 
failed to meet the criterion for noninferiority for pathologic outcomes among patients with 
stage II or III, mid to low rectal cancer.  
        A cohort of patients in the Academic Department of Surgery at the Townsville Hospital 
has successfully undergone laparoscopic restorative rectal cancer surgery since 2003. The 
technique there continues to be refined. Short term and long term outcomes after 
laparoscopic surgery for rectal cancer will be measured in this prospectively ongoing studied 
group of patients. There is an opportunity to assess aspects of   laparoscopic TME such as 
the quality of laparoscopic TME specimen, oncological clearance (number of lymph nodes 
retrieved, tumor clearance, and the integrity of rectal fascia), short term outcomes (like return 
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to bowel function, return to normal activity / energy levels complications), and long term 
outcomes (like quality of life, psychological adaptation to having to manage any necessary 
chemo radiotherapy) for laparoscopic TME patients. These measurements will be important 
in helping to refine and optimize techniques.   
        Laparoscopic rectal cancer surgery is, by nature, a more extensive and stressful 
procedure for the patient, compared to colon cancer surgery. Surgery induces a generalized 
stage of immunodepression (25). Cytokines produced by cells of the immune system and 
other tissues act as mediators of immune and acute phase response. C-reactive protein 
(which rises at 4 to 12 hours after surgery, usually peaks at 24 to 72 hours after surgery, and 
levels may remain elevated for approximately 2 weeks), tumor necrosis factor-alfa (TNF-
alfa), interleukin 1-beta (IL 1-beta), and interleukin 6(IL6, it usually peaks at 4 to 48 hours, 
median 8 hours, after surgery and falls rapidly thereafter with an uncomplicated 
postoperative course) are the major mediators of acute-phase response in humans. The 
postoperative levels of these cytokines have been found to correlate with the magnitude of 
surgery and the presence of complications. They have, therefore, been accepted as markers 
of tissue trauma after open surgery (26). However, there remains paucity of data examines 
how these factors relate to clinical progress after laparoscopic colorectal surgery, especially 
where it pertains to rectal cancer surgery. A prospective randomized trial found that tissue 
trauma, as reflected by systemic cytokine response, was less after laparoscopic resection 
than open resection of rectosigmoid carcinoma(which is different from rectal cancer) (27). In 
cancer surgery, immunosuppression induced by the disease and the surgery confers a 
growth advantage to micro metastasis (28). By using laparoscopic surgery, it is hoped that 
surgical trauma will be reduced, thus preserving the host immunity and improving survival. 
The effects of reduced systemic cytokine response on long term outcome remain unknown. 
        Although the objective outcome measures after surgical procedures are an important 
means of defining patient’s degree of health, the patient’s subjective perception and 
expectations, including the patient’s hopes, needs to be factored into that objective 
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assessment to determine the patient’s actual quality of life (29, 30).  Studies showing the 
quality of life after laparoscopic colon surgery are scanty, let alone laparoscopic rectal 
cancer surgery. A benefit in the early postoperative quality of life was reported in patients 
who underwent laparoscopic colorectal resection (31, 32), whereas a nonrandomized trial   
comparing long term quality of life after laparoscopic colorectal resection versus open 
colorectal resection for benign disease did not show a significant difference (33). However, 
most of the published reports included a heterogeneous group of patients with different 
diseases undergoing a variety of surgical procedures of different magnitudes. In addition, the 
patients in these studies mainly underwent laparoscopic colon cancer surgery or had 
laparoscopic abdominoperineal resection for rectal cancer. After the latter, they were left with 
a permanent stoma. However, with the recent advent of laparoscopic restorative rectal 
cancer surgery, the patients do not need a permanent stoma. The quality of life, particularly 
in this group of patients, has not been studied in any detail.          
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Chapter 2:  Overview in colorectal cancer treatment 
 
Overview 
      This chapter will give overview to understand the development of both colon and rectal 
cancer treatment. The comparison of the conventional open surgery versus the minimally 
invasive surgery was carefully demonstrated in all dimensions. The good understanding of 
the current updates in colorectal cancer treatment will lead to the critical thinking of more 
complex knowledge in the following chapter. This review of literature was already published 
in the peer-review journal.  
 
Surgical Treatment of Colorectal Cancer – a Review.  
(Int Surg. 2011; 96(2):120-6) 
      The rapid in development of surgical technology has had a major effect in 
surgical treatment of colorectal cancer. Laparoscopic colon cancer surgery has been 
proven to provide better short-term clinical and oncologic outcomes. However this 
quickly accepted surgical approach is still performed by a minority of colorectal 
surgeons. The more technically challenging procedure of laparoscopic rectal cancer 
surgery is also on its way to demonstrating perhaps similar short-term benefits. This 
article reviews current evidences of both short-term and long-term outcomes of 
laparoscopic colorectal cancer surgery, including the overall costs comparison 
between laparoscopic surgery and conventional open surgery. In addition, different 
surgical techniques for laparoscopic colon and rectal cancer are compared. Also the 
relevant future challenge of colorectal cancer robotic surgery is reviewed. 
 
      In 1987 (1) the success of laparoscopic surgery for gallbladder disease had a major 
effect on the development of present day laparoscopic surgery for various organs of benign 
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and malignant diseases. The first series laparoscopic colonic surgery was reported in 1991 
by Jacob et al. (2) Twenty patients with both benign and malignant colorectal diseases were 
safely resected laparoscopically with acceptable outcomes. With the aim to enhance 
postoperative recovery, reduce postoperative morbidity, reduce overall cost of treatment, 
and improve long-term survival for colorectal cancer patients, laparoscopic colorectal 
surgery had become a popular treatment option for colorectal cancer. A few years later, the 
interesting results from the first randomized controlled trial in 2002, emphasizing on the late 
outcomes of laparoscopic surgery for colonic cancer by Barcelona trial, Lacy et al. (3) stated 
the significant advantages of reduced blood loss, early return of intestinal motility, lower 
overall morbidity, and shorter duration of hospital stay in the laparoscopic-assisted group. 
Subgroup analysis from the study also revealed survival benefit that was mainly limited to 
stage III (Dukes’ C) disease. Although this finding might be explained by statistical 
phenomenon on subgroup analysis, it had already started the hope for this novel surgical 
approach on potential outcome improvement.  
      The objective of this review is to describe the comparison of available evidence between 
the conventional open approach and laparoscopic resection on short-term and long-term 
outcome of colorectal cancer treatment.  
 
Short-Term Outcome 
      Laparoscopic colorectal surgery has a steep learning curve due to its unique technique 
of working in multiple abdominal quadrants, control of vascular structures, creation of 
anastomosis, as well as retrieving large specimens in some patients (4, 5). Early randomized 
controlled trials suggest that the short term outcomes of laparoscopic colorectal surgeries 
are probably marginally better than the traditional open approach. However, after 
laparoscopic technique had been widely accepted, later reports (6, 7) demonstrated clear 
superiority of short-term outcome for the laparoscopic approach, including a reduction in 
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postoperative ileus, less postoperative pain and a concomitant reduction in the need for 
analgesics, earlier tolerance of diet, shortened hospital stay, quicker return to premorbid 
functional activity, less wound-related morbidity, improved cosmetic results, and a possible 
reduction in adhesion formation. 
      The Clinical Outcomes of Surgical Therapy (COST) study group (8) (1994–2001) 
reported the outcome from 48 institutions of 872 patients with colon cancer who were 
randomized to two groups: 435 laparoscopic resections and 437 open resections. The 
results from experienced surgeons who had done 20 or more laparoscopic resections 
showed longer operating time, but shorter recovery time and hospital stay, and trend toward 
lower intraoperative complications. There was no significant difference in morbidity and 
mortality, tumor recurrence, or overall survival after 4.4 years of follow-up. The COlon cancer 
Laparoscopic or Open Resection (COLOR) trial (9) is also a multicenter study that enrolled 
1248 patients with colon cancer randomized to two groups: 627 laparoscopic resections and 
621 open resections. The laparoscopic group had longer operating times but less blood loss, 
early recovery of bowel function, fewer analgesics requirement, and shorter hospital stay. 
There was no significant difference in radicality of resection and postoperative morbidity and 
mortality. The Medical Research Council (MRC) Conventional vs. Laparoscopic-Assisted 
surgery in Colorectal Cancer (CLASICC) trial (10) included 794 patients who were 
diagnosed with colon and rectal cancer (526 laparoscopic resections and 268 open 
resections) from 27 United Kingdom centers between 1996 and 2002. The study concluded 
that laparoscopic-assisted surgery for cancer of the colon is as effective as open surgery in 
the short term and is likely to produce similar long-term outcomes. However, there were 34% 
of conversions from laparoscopic to open surgery among the rectal cancer patients. Patients 
with converted treatment had raised complication rates. The impaired short-term outcomes 
after laparoscopic-assisted anterior resection for cancer of the rectum do not yet justify its 
routine use. The meta-analysis of 12 randomized controlled trials on short-term outcome 
comparing laparoscopic resection for colorectal cancer to open resection reported by 
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Abraham et al. (11) in 2004 showed that it took 30% longer to perform the operation in the 
laparoscopic group, but there was less morbidity, earlier return of bowel function (33%), 
reduced analgesia requirements (37%), and reduced hospital stay (20%). There was no 
difference in perioperative mortality or oncologic clearance in either group. The superior 
short-term outcome with laparoscopic resection is supported by the reports on perioperative 
immunologic response. A recent prospective study from China (12) on 68 colorectal cancer 
patients (35 laparoscopic resections and 33 open resections) showed significant earlier 
return of bowel function and reduction of hospital stay in the laparoscopic resection group. 
Total lymphocytes, CD4 T cell, and CD8 T cell levels were significantly higher in 
laparoscopic resection compared with open resection, especially on postoperative day 4. 
This study confirmed the results from other studies (13–16) for better reserved cellular 
immune responses in patients undergoing laparoscopic colorectal resections. In addition, 
more aggressive phenotype of cancers also found with more profound immunosuppression 
demonstrated after open surgery (17).  Milasˇien et al. (18) also reported that better cellular 
immunity correlated with higher postoperative survival rates.  
      Short-term outcomes from the Australasian randomized clinical study comparing 
laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial 
(19), a multicenter prospective randomized clinical trial, included 601 colon cancer patients. 
All the patients were enrolled by 33 surgeons from 31 Australian and New Zealand centers 
between January 1998 and April 2005. 294 patients were allocated to laparoscopic-assisted 
surgery. Statistically significant differences in quicker return of gastrointestinal function and 
shorter hospital stay were demonstrated in favor of laparoscopic-assisted resection. The 
infective complications increased significantly in cases converted from laparoscopic-assisted 
to open procedures. There was no statistically significant difference found in postoperative 
complications, reoperation rate, or perioperative mortality. Interestingly, the quality of life 
from the ALCCaS trial was recently reported by McCombie AM. et al (20) in 2018. Of the 592 
patients enrolled in ALCCaS, 425 completed at least 1 quality-of-life measure at 4 time 
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points (71.8% of cohort). Symptoms Distress Scale, the Quality of Life Index, and the Global 
Quality of Life Score were used to measure the patient symptoms and quality of life 
preoperatively and at 2 days, 2 weeks, and 2 months postoperatively. The study 
demonstrated a short-term gain in quality of life maintained at 2 months postsurgery for 
those who received laparoscopic relative to open colonic resection; Symptoms Distress 
Scale (p< 0.01), Quality of Life Index (p< 0.01), and Global Quality of Life (p< 0.01). 
 
Cost 
      The concern about potential increased cost of laparoscopic colorectal resections has 
always been considered. However, laparoscopic colorectal resections were found to be 
significantly cheaper than conventional open resections because of the reduced hospital 
stay, despite higher operative spending (21). A report from Australia by Norwood et al. (22) 
compared hospital cost using Hospital Patient Costing System, including costs from nursing 
interventions (calculated in minutes). Ninety-seven patients (53 laparoscopic resections, 44 
open resections) were analyzed. The median total cost of the procedure was equivalent: 
AUS$9698/£5631 (AUS$3862–90,397) in the open group and AUS$10,951/£6219 
(AUS$2337–66,237) in the laparoscopic group. The laparoscopic group showed more 
benefit in reduction of nursing intensity (80 versus 58.5 hours), and the significant reduction 
of nursing intensity was demonstrated after exclusion of laparoscopic patients who 
underwent conversion (80 versus 54 hours; P=0.01). Furthermore, a large Dutch multicenter 
trial recently confirmed in 2017 (23) that the laparoscopic approach for colon cancer 
resection resulted in a significant cost reduction when compared to open resection. 
Retrospective analyses using a population-based database included all elective resections 
for a T1-3N0-2M0 stage colorectal cancer, between 2010 and 2012 in 29 Dutch hospitals. 
Ninety-day hospital costs were measured uniformly in all hospitals based on time-driven 
activity-based costing. For colon cancer surgery (N = 4202), laparoscopic resection was 
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significant less expensive than open resection in all subgroups. Particularly in patients ≥75 
years and ASA I-II, laparoscopic resection was associated with 46% less mortality (P = 
0.05), 41% less severe complications (P < 0.001), 25% less hospital stay (P = 0.013), and 
65% less ICU stay (P < 0.001). However, for rectal cancer surgery (N=2328), all 
laparoscopic subgroups had significantly higher total hospital costs. 
 
Long-Term Outcome 
      Several evidences from early basic science studies suggested that in the right setting, 
laparoscopic surgery will result in a better long-term oncologic outcome by more 
preservation of immunologic functions (24–26). Preservation of the body’s immunologic 
function, particularly cellular immunity immediately after surgery, is an essential defense to 
potentially prevent cancer recurrence (27). Significantly less physiologic alterations during 
this critical perioperative period can be achieved by laparoscopic surgery, which is relating to 
less tissue trauma (24–26). Interestingly, these potential advantages have not been 
translated into better long-term outcomes in human settings. 
      Jayne et al. (28) reported the evidence on long-term outcomes of the UK MRC CLASICC 
trial after 5 years of follow-up. They described no difference in the overall survival, disease-
free survival, local or distant recurrence between laparoscopic resection and open resection. 
Long-term quality of life was also comparable between groups. These data, together with 
other multicenter randomized trials (9, 10, 29) and meta-analyses (12, 30, 31), are applied 
not only for colonic caner but also for rectal cancer. As already mentioned, the steep 
learning curve for laparoscopic colorectal surgery may have a major effect on unimproved 
oncologic outcomes. Expert surgeons who participated in the trials at that time were 
relatively inexperienced. Unexpectedly very high conversion rates from the 3 multicenter 
prospective trials also confirmed this hypothesis: COST, 21%; COLOR, 17%; CLASICC, 
29% (32–34). However, the up-to-date trial by more experienced laparoscopic surgeons is 
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still debatable if better cancer long-term outcome can be expected from laparoscopic 
colorectal surgery. 
      There is conflicting data on the conversion rate, which may affect morbidity, mortality, 
and overall survival. Some studies have suggested that conversion does not influence 
outcome (35). Casillas et al. (36) reported a case-match study from the Cleveland Clinic with 
51 (12%) cases converted to open surgery from 430 laparoscopic colectomies performed 
between 1999 and 2002. The converted cases were matched for operation and age. They 
found that conversion does not result in inappropriately prolonged operation times, increased 
morbidity or length of stay, increased direct costs, or unexpected readmissions compared 
with similarly complex laparotomies. Other investigators (37, 38) found a correlation between 
conversion and survival disadvantages. Data from 5 years of follow-up in the CLASICC trial 
(28) also demonstrated this clear survival disadvantage. The adverse impact of conversion 
was significant only for overall survival not disease-free survival. This finding is not 
attributable to a surgeon-related factor. Although advanced cancer pathology, which was 
cited as the most common reason for conversion, other reasons (e.g., obesity, technical 
difficulties, complication) appear to have a bad outcome independent of surgical experience. 
      Port site recurrence had been one of the major concerns for laparoscopic surgery for 
colorectal cancer. This unusual pattern of recurrence was first reported in 1991 (39, 40). The 
incidence from case series ranged from 1% to 21%, and 80% of cases presented within 12 
months of surgery (41). The incidence from open surgery is 1.1% 61.5% (42). This type of 
recurrence in laparoscopic colorectal surgery for malignancy might be overstated. Data 
reported from prospective voluntary audit from 1992 to 1995 showed an incidence of 1.1%, 
which is similar to open surgery (43). It also appeared that these types of recurrences are 
not observed in the latest updates from large randomized control trials: COST, 0.5%; 
COLOR, 1.3%; Barcelona trial, 0.9% (32, 34, 44).  
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      Experimental (45) and clinical data from single center, nonrandomized, and largely 
heterogeneous studies (46–50) support that adhesion formation was reduced after the 
laparoscopic procedure. Incisional hernia is also a cause of postoperative morbidity and 
mortality. Several studies have suggested that the rate of incisional hernia was reduced after 
laparoscopic colorectal surgery (46, 48) owing to the absence of a large abdominal wound 
(51, 52). The MRC CLASICC (53) reported long-term complications in 411 patients with 
adhesive intestinal obstruction and incisional hernia. The results did not confirm that 
laparoscopic surgery reduced the rate of adhesive intestinal obstruction and incisional hernia 
after colorectal cancer surgery. Trends suggested that a reduction in conversion to open 
surgery and elimination of port site hernias may produce such an effect.  
 
Rectal Cancer 
      According to anatomic limitation, laparoscopic surgery for rectal cancer involves several 
challenges that lead to a longer learning curve when compared with laparoscopic colonic 
surgery. Laparoscopic surgery for rectal cancer is limited to specially trained surgeons; as a 
result the reports for this procedure are scanty. Better visualization with the laparoscopic 
approach for rectal dissection reduced blood loss and surgical stress, which also leads to 
faster recovery (54). However, laparoscopic surgery for rectal cancer is still not universally 
accepted and concerns persist regarding the adequacy of oncologic resection. The 
CLASICC trial (28) reported a nonsignificant increased rate in radial resection margin 
positive in patients undergoing laparoscopic anterior resection (6.3% for open resection 
versus 12.4% for laparoscopic resection). This also did not affect the difference in local 
recurrence rate at the 5-year follow-up. These data are reassuring—laparoscopic surgery for 
rectal cancer is feasible with benefits of shorter outcomes and comparable long-term 
oncologic outcomes.  
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      Many investigators have called for a change in the technical approach of the 
abdominoperineal resection (APR). The remaining difference in local recurrence rate 
between rectal cancer treated by an anterior resection and those patients undergoing APR, 
which carries an 8.8% increased risk, relates to the anatomic location of the tumor. The 
introduction of cylindrical APR is now well recognized to rectify the situation (55). This 
difference has been attributed, in part, to the smaller tissue volume around the tumor and the 
higher rate of cancer at circumferential resection margins (CRM) after APR (56–58). A 
recent multicenter study reported by West et al. (59) comparing 176 extralevator APR from 
11 European colorectal surgeons to 124 standard APR from 1 United Kingdom center 
demonstrated significant more removed tissue from outside the smooth muscle layer per 
slide (median area 2120 versus 1259 mm2; P=0.001) leading to a reduction of 
circumferential involvement (from 46.6% to 20.3%; P=0.001), and intraoperative perforation 
(from 28.2% to 8.2%; P=0.001). However, extralevator surgery was associated with an 
increase in perineal wound complications (from 20% to 38%; P50.019). This is interesting 
when compared to a report from Memorial Sloan-Kettering in 2007 (60).  One hundred nine 
patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy 
followed by total mesorectal excision (TME) were studied. A complete pathologic response 
was found in 16% of patients. In patients with residual tumor, the median CRM was 10 mm. 
This was similar to the patients undergoing either low anterior resection or standard APR. 
There were only 2% of patients who had CRM of less than 1 mm. Genitourinary dysfunction 
results in significant morbidity when it occurs after rectal resection. Studies comparing 
differences in rates of genitourinary dysfunction after laparoscopically assisted or open rectal 
cancer resections are limited. Quah et al. (61) reported no statistically significant difference 
in bladder dysfunction between laparoscopically assisted and open TME for rectal cancer. 
However, impotence and ejaculation dysfunction had significantly higher rates with the 
laparoscopic resection. A study from the United Kingdom (62) also reported a trend toward 
male sexual dysfunction. However, it was also stated that laparoscopic rectal resection did 
not adversely affect bladder function. Nerve identification during resection may reduce the 
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rate of postoperative genitourinary dysfunction (63–65). Junginger et al. (63) demonstrated 
in their study of 150 patients who underwent TME for rectal cancer that intraoperative visual 
inspection of the pelvic autonomic nervous system was achieved 72% of the time. Patients 
who had complete identification of the pelvic autonomic nerves experienced a significant 
reduction in postoperative urinary dysfunction. 
      Interestingly, local failures have still been a problem. Despite of total mesorectal excision 
and preoperative radiation therapy, abdominoperineal resection (APR) was reported to have 
significantly worse results than anterior resection with more circumferential resection margin 
positivity and local recurrences. Both anatomic aspects of the advanced tumor within a 
challenge location and technical difficulties associated with standard APR (66-68). During 
“standard” APR, the reduced volume of mesorectum in the lower rectum increased the 
chance of reaching the anal sphincters at the circumferential margin, leaving a “waist” in the 
specimens. In a “call for a change of approach,” Nagtegaal et al (67) described the poor 
prognosis of patients who had undergone standard APR leading to a high frequency of 
circumferential margin involvement either by the tumor itself or the perforation, or both during 
the dissection. For these reasons, an alternative approach using a wide perineal resection 
has been proposed. Holm et al (69-70) reported the extralevator APR which was optimally 
performed in the prone jackknife position. It was recommended that the rectum should be 
mobilized from the abdomen until the seminal vesicles in men and upper vagina in women. 
The stoma was then made and the abdominal closure was performed. The patient was 
turned to a ventral position. The extended rectal excision was performed under direct vision. 
The coccyx excision was recommended to facilitate an adequate visualization of the 
posterior pelvis that was previously dissected through the abdomen. Lateral dissection was 
extended to the origin of the levator muscles at the pelvic sidewall. The technique aimed to 
remove more surrounding tissue around the tumor and thus decrease perforations and rates 
of circumferential resection margin involvement. Furthermore, adequate and direct 
visualization could enhance a better dissection through the correct anatomic planes to 
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prevent intraoperative tumor perforation. More recently, West et al (68) had confirmed that 
extralevator APR using prone jackknife position led to a reduction in circumferential 
resection margin positivity and intraoperative perforations.  
 
Chemotherapy and Radiotherapy 
       Surgery for locally advanced rectal cancer (LARC) has a significant impact on the 
patient, and severe complications occur in up to 22% of patients (71). In addition, sphincter 
preservation is possible in only 50% of patients with low-rectal cancer (72). Organ-
preserving strategies and quality of live improvement have become major interests within 
this group of patients. The guidelines of the National Comprehensive Cancer Network 
(NCCN) for LARC recommend a multidisciplinary approach with neoadjuvant chemo 
radiotherapy (CRT), surgery using TME principles, and adjuvant chemotherapy (73). 
Neoadjuvant CRT was defined as standard mainly because of its potential to decrease 5- 
and 10-year pelvic recurrence rates (74). However, whether long- or short-course 
radiotherapy is preferable remains matter of debate.  
      A wide range of drugs, including oxaliplatin as an adjunct to CRT, failed to demonstrate 
clear benefits in several high-quality studies and this was due mainly to increased toxicity 
(75-76). However, more recent data showed improved disease-free survival when adding 
oxaliplatin to both preoperative CRT and postoperative chemotherapy (77). Several further 
phase II trials showed similar promising results without jeopardizing planned CRT or 
increasing surgical complications (78-81), labelling the concept of total neoadjuvant 
chemotherapy as safe and feasible. Splitting of adjuvant chemotherapy by delivering at least 
some cycles before CRT and the remaining post-surgery has also been described as an 
alternative (82-83). A randomized trial in North America (NRG GI002) is accruing patients for 
a total neoadjuvant approach. 
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      Furthermore, the combination of long-term  morbidity  with  pelvic  irradiation  and  
widespread  application  of  TME  principles  to  decrease  local  recurrence,  a  subset  of  
patients  may  be  eligible  to  avoid  preoperative  radiation  and  to  undergo  solely  
neoadjuvant  systemic  chemotherapy. Large  studies  are  ongoing (84) and  today this  
approach  is  used  primarily  in  trial  settings. The  randomized phase  III  PROSPECT  
(Preoperative  Radiation  or  Selective Preoperative  Radiation  and  Evaluation  Before  
Chemotherapy  and  TME)  trial  is  assessing  this  strategy  in  patients with  
uncompromised  CRM  (ClinicalTrials.gov  Identifier: NCT01515787). 
 
Robotic Surgery 
      Limitations inherent in conventional laparoscopic surgery can be overcome by the use of 
robot. The clear advantages of robot are increased dexterity of instruments, precision, 3-
dimensional visuals, a steady camera, and intuitive movements that may help obtain better 
oncologic and overall surgical outcomes (86, 87). It has been well documented that robotic 
surgery has passed its infancy for some subspecialties (e.g., urology and gynecology). The 
data have shown the equality and sometimes superiority of robotic surgery versus 
conventional laparoscopic surgery (88–92).   
      Reports on robotic surgery for colorectal cancer are still limited. Potential advantages of 
the robot in colorectal surgery are similar to those in other fields: less operative blood loss, 
better oncologic technical dissection in rectal cases, and increased ease of dissection in a 
confined space. Laparoscopic TME is limited both by the rigidity of the instruments and the 
restricted range of motion for the surgeon. The robot overcomes these limitations and allows 
for more precise oncologic dissection (93). The high conversion rate of laparoscopic surgery 
for rectal cancer (<30%) may have an advantage in implementing robot surgery (10). Three-
dimensional visualization also is providing the ability of better nerve sparing TME (91). Baik 
et al. (95) reported on a randomized controlled trial of 36 patients: 18 who underwent robotic 
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low anterior resection using the da Vinci Surgical System, and 18 patients who underwent 
conventional laparoscopic low anterior resection. No difference was found in operating time, 
hemoglobin level change, conversion rate, or quality of the specimen between the 2 groups. 
The significant difference was demonstrated in the average length of stay (6.9 61.3 days in 
robotic resection group; 8.7 61.3 days in laparoscopic group; P<0.001).  
      Repositioning is a major obstacle for robotic surgery when more than 1 field of dissection 
is required. The hybrid procedure laparoscopic splenic flexure mobilization and vascular 
pedicle transection combined with robotic total mesorectal excision may be 1 solution to be 
considered. However, operative time may be reduced by an experienced team or by using 
the nonrepositioning technique, as reported by Hellan et al. (95).  
      The  most  important  study  in  the  field  was  published  recently:  The  ROLARR  
study,  an  international  multicenter  prospective  trial,  randomly assigned  471  patients  to  
either  conventional  laparoscopic  or robotic-assisted  resections (96).  The  study  failed  to  
demonstrate significant  benefits  of  robotic  surgery  regarding  the  main  outcomes  of  
CRM  positivity,  TME  quality,  intra-  and  postoperative complications,  and  30-day  
mortality.  However, the wide range of experience among operating surgeons was criticized. 
      In conclusion, laparoscopic surgery for colorectal cancer has become popular among 
patients and surgeons. In recent years, it has been confirmed that laparoscopic surgery for 
colon cancer demonstrates better short-term outcome, oncologic safety, and equivalent 
long-term outcome. For rectal cancer, laparoscopic surgery can be more complex depending 
on the tumor location. TME, sphincter preservation, and autonomic pelvic nerve preservation 
provide even more challenge for colorectal surgeons to minimize local recurrence, and at the 
same time, to maximize quality of life for the patients. Unlike laparoscopic surgery for colon 
cancer, there is not enough evidence to reach any conclusion on its long-term oncologic 
outcome. Large randomized control trials need to be conducted to assess the long-term 
outcome of laparoscopic surgery for rectal cancer to reach the same conclusions.  
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Chapter 3:  Laparoscopic surgery for rectal cancer 
 
Overview 
      This chapter contains the most important part of the thesis. This was the first published 
data comparing laparoscopic ultralow anterior resection versus laparoscopic pull-through 
with coloanal anastomosis for rectal cancers. The rational of combining transanal dissection 
with the routine transabdominal TME was explained in detail. The preoperative, 
intraoperative and postoperative parameters were collected and analyzed. The proposed 
technique may overcome the challenge in rectal cancer dissection in deep and narrow 
pelvis.  
 
Laparoscopic Ultralow Anterior Resection versus 
Laparoscopic Pull-through with Coloanal Anastomosis for 
Rectal Cancers – a Comparative Study.  
(Am J Surg. 2011; 202(3):291-7) 
BACKGROUND: Ultralow anterior resection for mid and distal rectal cancers has been 
reported routinely performed using either a laparoscopic ultralow anterior resection 
(LAR) or laparoscopic pull-through with coloanal anastomosis (LPT). This study 
evaluated the postoperative and functional outcomes. METHODS: Between January 
2007 and December 2008, 40 consecutive patients had laparoscopic surgery for rectal 
cancers. The data were prospectively collected. RESULTS: There were 21 patients (21 
men; mean age 61.2+3.2 years standard error of the mean (SEM)) in the LAR group 
and 19 (16 men; mean age 61.4+2.4 years SEM) in the LPT group. Tumor 
characteristics, adjuvant therapy given, mean follow-up (overall 33.5+1.4 months 
SEM), intraoperative time, blood loss, mesorectum quality, conversion rate (LAR n=2, 
LPT n=1), pain score, time for ileostomy to function, subsequent incontinence scores, 
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and complication rates (LAR n=7, LPT n=9) were not different between groups, but 
benign anastomotic strictures were higher after LPT (n=4, LAR n=0, P=0.042). The 
latter was associated with chemoradiotherapy (P=0.015). There were 2 systemic 
cancer recurrences both in the LPT group but no local recurrences to date. 
CONCLUSIONS: The LAR technique may have less risk of anastomotic strictures, 
particularly with adjuvant therapy. LPT may be considered selectively for a bulky 
distal rectal tumor in a small pelvis with comparable functional results. 
 
      Laparoscopic colectomy for colon cancer has recently been confirmed to provide 
equivalent oncologic results to traditional open surgery with advantages of early feeding, 
less pain, shorter hospital stay, earlier return to normal daily activities, and perhaps lower 
long-term risks of incisional hernias and adhesions (1– 4). Even though laparoscopic rectal 
cancer surgery is technically more challenging compared with laparoscopic colon surgery 
because it involves total mesorectal excision (TME) in a limited pelvic cavity, it has recently 
been reported to be feasible and safe and offers the advantages of laparoscopic surgery (5–
7); however, long-term follow-up of local recurrence, disease-free survival, and overall 
survival have not yet been consistently confirmed. Various laparoscopic-assisted and 
laparoscopic rectal cancer surgery techniques have been introduced including (1) 
mobilization of splenic flexure and ligation of the inferior mesenteric vessels laparoscopically 
and then performing the pelvic dissection through a small transverse supra- pubic incision, 
(8, 9) (2) using a hand port technique to assist the laparoscopic procedure, (10, 11) and (3) 
performing the entire abdominal and pelvic procedure laparoscopically (12). The last 
technique has the advantage of better visualization of the mesorectum, nearby nerves, and 
other vital structures during deep pelvic dissection with the magnification of the laparoscope 
(12). With the total laparoscopic approach, 2 techniques of distal pelvic dissection, resection 
of specimen, route of specimen extraction, and subsequent coloanal anastomosis have been 
reported.  
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      First, with the laparoscopic ultralow anterior resection (LAR), the entire pelvic dissection 
and division of the distal rectum is performed with an abdominal laparoscopic technique. The 
specimen is then extracted through a protected lower abdominal wound or defunctioning 
ileostomy site, (12) and coloanal anastomosis is performed (at anorectal junction) with a 
laparoscopic intracorporeal double-cross staple. In the second laparoscopic pull-through 
coloanal anastomosis (LPT) approach, a transanal approach is used to complete the distal 
pelvic dissection, extract the specimen, and perform a hand-sewn coloanal anastomosis (at 
the dentate line) (13–15). Both techniques may incorporate a colonic pouch or coloplasty to 
improve postoperative bowel function (16). The conceivable advantages of LAR include 
more control in specimen extraction against tumor spillage using commercially available 
wound protectors and better preservation of anorectal function (17, 18). By contrast, LPT 
facilitates difficult distal pelvic dissection via the transanal approach and extracts the 
specimen through a natural orifice although an incision for a defunctioning stoma may still be 
required.  
      To date, there have not been any studies that have compared the outcomes of LAR and 
LPT when both were performed routinely. A prospective comparative study was conducted 
to assess the early postoperative and functional outcome of the 2 techniques. 
 
Methods 
      Between January 2006 and December 2008, patients with rectal cancer operated on by 
a single surgeon were included in a prospective comparative study that was approved by the 
Institutional Review Board. Patients undergoing laparoscopic abdominoperineal resection 
and those who had a tumor invading an adjacent organ, high anterior resection, and 
associated disease (eg, polyposis, ulcerative colitis, and secondary cancer) necessitating 
proctocolectomy were excluded. The preoperative assessment included physical 
examination, colonoscopy with biopsy, endorectal ultrasonography, abdominopelvic 
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computed tomography (CT) scan, serum carcinoembryonic antigen (CEA), a chest x-ray, 
and pelvic magnetic resonance imaging. Patients with pelvic magnetic resonance imaging 
showing a locally advanced tumor; a tumor penetrating through the rectal wall (T3), and/or a 
tumor with lymph node involvement without any evidence of distant metastases were given 
the option of preoperative chemoradiotherapy (45 Gy). Otherwise, patients with confirmed 
inadequate radial resection margin (less than 3 mm) and/or specimen-confirmed lymph node 
metastases were offered postoperative adjuvant chemoradiotherapy as appropriate. 
Although offered neoadjuvant therapy, most patients in this reporting regional service 
draining a large distant rural population preferred to have chemoradiotherapy only after it 
was proven to be indicated on the histopathology report. The LAR or LPT technique was 
selected by alternating allocation by sequence on the day of surgery. Tumors were staged 
postoperatively using the 6th edition of the American Joint Committee on Cancer clinical 
tumor node metastasis (TNM) classification. 
 
Surgical technique 
      Surgery was performed 6 to 8 weeks after chemoradiotherapy as appropriate. Patients 
were operated on by 1 colorectal surgeon experienced in laparoscopy. All patients had 
epidural analgesia as well as fast-track multimodal perioperative management except for 
bowel preparation. Our technique for LAR has previously been described with video (12). In 
the LPT technique, port placement was similar except that a 5.5-mm port was used instead 
of the 15-mm port in the right lower quadrant. The operative technique has been described 
previously by Person et al. (15) A loop ileostomy was matured, and a pelvic suction drain 
was used selectively in both groups. Ileostomy reversal was scheduled 12 weeks later or 
after the completion of chemoradiotherapy; confirmation of anastomosis integrity was 
performed with a Gastrografin enema (Bayer New Zealand Limited, North Shore, Auckland). 
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Quality of surgery 
      The rectal specimen was examined in the operating room by a trained independent 
observer to assess the completeness of mesorectal excision and the distal resection margin. 
For pathological assessment, the surface of mesorectum was inked before slicing to assess 
the circumferential resection margin. Microscopic assessment was performed to define the 
extent of tumor infiltration through the bowel wall (pT/ypT), lymph node involvement 
(pN/ypN), and distal and circumferential resection margins.  
Definition of conversion and morbidity  
      Conversion to an open operation was defined as extension of the extraction incision over 
5-cm long (including conventional midline laparotomy or the need to perform any part of the 
procedure besides maturing of the ileostomy through the incision). The reasons for 
conversion were recorded. Patients in either groups who subsequently needed 
abdominoperineal resection or any procedural changes that violated the allocation (eg, 
changing from LAR to LPT) were also classified as conversions. Morbidity was defined as a 
surgical postoperative complication of grade III, IV, and V as classified by Dindo et al. (19) 
Grade III included postoperative complications that required surgical, endoscopic, or 
radiologic intervention with or without general anesthesia. Grade IV included life-threatening 
complications requiring intensive care unit management. Grade V complications caused 
postoperative death. Pelvic sepsis was defined as clinical pelvic infection (ie, anastomosis 
leakage, pouch leakage, or isolated pelvic abscess) but not asymptomatic radiologic leaks. 
Any infection suspected on the basis of fever, abdominal pain, gas, pus or fecal discharge 
from the drain, rectal discharge, or rectovaginal fistula was confirmed by an immediate pelvic 
CT scan with water soluble contrast enema.  
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Data collection, follow-up, and statistical analysis 
      Data were prospectively collected for age; sex; body mass index; American Society of 
Anesthesiologists grade; incision length; tumor stage; indication for surgery; duration of 
operation; amount of blood loss; tumor location; tumor size; distal margin; TME quality 
(Quirke classification) (20); pelvic size; conversion; and postoperative data including 
passage of flatus, hospital stay, morbidity, and mortality. Patients were asked to score their 
maximum pain experienced on a visual analog pain score of 0 to 10 at the time of discharge, 
10 being the worst pain. Functional outcome assessment was with the Wexner incontinence 
score (21) at 3 months after ileostomy closure. Sexual function was also asked at the same 
visit. All patients had an office rigid sigmoidoscopy at 3 months after surgery. An 
anastomotic stricture was defined as failure to pass the rigid sigmoidoscope through the 
anastomosis.  
      Patients were followed up at 3 monthly intervals for 2 years and 6 monthly intervals for 
the subsequent 3 years. Serum CEA levels were measured before each visit and the 
patients underwent a thorough clinical examination including digital rectal examination 
and/or rigid sigmoidoscopy. A CT scan of the abdomen, pelvis, and thorax was performed 
annually. Patients also underwent a follow-up colonoscopy at 1 year, earlier if the colon had 
not been completely screened before surgery. Further appropriate investigations were 
otherwise performed based on symptoms, clinical findings, and serum CEA levels.  
      Statistical analysis was performed by using the Fisher exact probability test, the chi-
square test, and the Mann Whitney U test for differences between the groups. To minimize 
the statistical discrepancies caused by small sample size, the exact significance was 
calculated by using the SPSSR Exact Test (SPSS, Inc, Chicago, IL), and statistical 
significance was assigned to any P value < 0.05. 
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Results 
      Forty consecutive patients who underwent LAR and LPT for rectal cancer were 
prospectively evaluated (Table 1). No patients meeting criteria were excluded. Every patient 
had good control of bowel movements preoperatively evaluated by a detailed history and 
precise proctologic examination. There were no significant differences between the mean 
age, sex, body mass index, American Society of Anesthesiologists grade, location of the 
tumor above the anal verge, tumor size, tumor stage, tumor grading, distal resection margin, 
and resected mesorectum quality (20) between the LAR and LPT groups. All the specimens 
in both groups had adequate circumferential resection margins. The proportions of patients 
who received adjuvant chemoradiotherapy were also not significantly different.  
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Table 1 Patient demographics in patients who had LAR and LPT 
                                                                    LAR (n=21)                  LPT (n=19) 
Age (y)*                                                                                61.3+2.40                       61.2+3.15 
Male/female ratio                                                                       21/0                              16/3 
Body mass index (kg/m2)*                                                      26.1+0.8                         26.7+1.6 
ASA score†                                                                             2 (1–3)                          2 (1–3) 
Lower margin of tumor from anal verge‡   
 <8 cm                                                                        11 (52.4)                        10 (52.6) 
 8–12 cm                                                                    10 (47.6)                          9 (47.4) 
Tumor greatest diameter‡ 
 <4 cm                                                                        15 (71.4)                        15 (78.9) 
 >4 cm                                                                         6 (28.6)                          4 (21.0) 
Tumor stage‡ 
 pT/ypT0                                                                       1 (4.8)                              0 (0) 
 pT/ypT1                                                                       2 (9.5)                           2 (10.5) 
 pT/ypT2                                                                      8 (38.1)                          4 (21.1) 
 pT/ypT3                                                                    10 (47.6)                        13 (68.4) 
Nodal stage‡ 
 pN/ypN0                                                                    12 (57.1)                        13 (68.4) 
 pN/ypN1                                                                      9 (42.8)                         6 (31.6) 
Liver metastasis                                                                       2 (9.5)                            1 (5.3) 
Tumor differentiation‡ 
 Well differentiated                                                      6 (28.6)                           2 (10.5) 
 Moderately differentiated                                          13 (61.9)                         13 (68.4) 
 Poorly differentiated                                                      0 (0)                             4 (21.1) 
Quirke mesorectum quality‡ 
 Grade 1                                                                      1 (4.8)                            3 (15.8) 
 Grade 2                                                                     6 (28.6)                           7 (36.8) 
 Grade 3                                                                   14 (66.7)                           9 (47.4) 
Distal resection margin‡ 
 1–1.9 cm                                                                    7 (33.3)                          5 (26.3) 
 2–5 cm                                                                     12 (57.1)                        10 (52.6) 
 >5 cm                                                                         2 (9.5)                           4 (21.0) 
Preoperative radiation‡                                                           3 (14.3)                              0 (0) 
Postoperative radiation‡                                                          6 (28.6)                          7 (36.8) 
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There were no significant differences between LPT and LAR using the Mann-WhitneyUtest and the Fischer exact 
test as appropriate. ASA, American Society of Anesthesiologists. *Values in mean (SEM). †Values in median 
(range). ‡Values are n (percentage). 
 
 
      All LAR and LPT patients had 5-cm colonic j-pouches. The operating times, extraction 
wound size, estimated blood loss, and conversion rates showed no significant differences 
between the 2 groups (Table 2). Two conversions in the LAR group were because the 
operating table failed to tilt adequately despite normal testing before the procedure and 
because of inadequate blood supply of the proximal colon after extraction and excision of the 
segment with rectal cancer. Conversion to a laparotomy ensured a well-vascularized distal 
transverse colon successfully brought down for anastomosis. The LPT patient who needed 
conversion had persistent hypotension upon induction of the pneumoperitoneum.  
 
Table 2 Operative parameters in patients who underwent LAR and LPT 
                                                                                       LAR (n=21)         LPT (n=19) 
Operating time (h)*                                                            2.7+0.2             2.9+0.1 
Extraction wound size (cm)*                                              3.1+0.3                NA 
Estimated blood loss (mL)*                                               46.2+9.2           78.6+18.3 
Conversion†                                                                        2 (9.5)              1 (5.3) 
There were no conversions of LAR to LPT because of technical difficulties. There were also no conversions to 
abdominoperineal resection in both groups. No significant differences between the LAR and LPT groups using 
the Mann-Whitney U and Fischer exact test where appropriate. *Values in mean (SEM). †Values are n 
(percentage). 
 
      Table 3 shows that the postoperative pain scores, time for ileostomy to function, 
hospital stay, postileostomy closure bowel movements, and incontinence scores were not 
different between LAR and LPT patients. One patient in the LAR group and 4 patients in the 
LPT group had ileus of 5 days duration or longer; all ileuses resolved within 6 days in the 
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LAR group and 7 days in the LPT group (P=not significant). The mean length of hospital stay 
was longer in the LPT group (11.5 vs 6 .8 days) although not statistically significant. This 
was likely related to the higher but again not significant incidence of failed fast-track 
feeding/prolonged ileus in the LPT group. Interestingly, at the 2-year follow-up (mean follow-
up 24.41.3 months SEM; LAR and 24.51.5 months SEM; LPT, P=not significant), the LPT 
group showed a trend of better control in bowel movement (Wexner incontinence score of 
1.3 vs 3.3). Improvement in bowel function was found in both groups over time (Wexner 
incontinence score of 1.0 vs 1.1, mean follow-up 33.4+1.3 months SEM; LAR and 33.51.5 
months SEM; LPT, P=not significant).Table 4shows that there were no significant 
differences in the total complications rates between the LAR (n=7) and LPT (n=9) patients. 
The only mortality was in a high-risk patient who died of a cerebrovascular accident after 
LPT. The other medical complications were chest infections and urinary tract infections. 
There were no anastomotic leaks as detected clinically or by the Gastrografin enema before 
closure of the ileostomy. However, the incidence of anastomotic strictures was significantly 
higher in the LPT group. These strictures all developed late, occurring at a median of 14 
(range 6 –28) weeks after surgery. There was a significant association with postoperative 
chemoradiotherapy in this group (P=0.015). All did not respond to the dilatation and required 
reoperation; 1 patient preferred to have a completion abdominoperineal resection, and 
anastomotic revisions were successful in 2 patients who had their ileostomies closed 
eventually. The revision of the anastomosis failed in 1 patient because of inadequate colonic 
vascular supply resulting in permanent colostomy. Two patients with pelvic collections 
detected on a CT scan because of prolonged ileus/failure of fast-track feeding improved with 
antibiotics, intravenous fluids, and nasogastric tube suction. 
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Table 3 Postoperative outcome measures comparing LAR with LPT 
                                                                                        LAR (n=21)        LPT (n=19) 
Pain score*†                                                                     5.9 (7.6)              6.4 (1.6) 
Time for ileostomy to start function*                                 2.6 (0.3)              3.6 (0.6) 
Hospital stay*                                                                   6.8 (0.7)             11.5 (3.7) 
At the 2-year follow-up 
Bowel movements*‡                                                       3.5 (0.9)               2.4 (0.6) 
Wexner incontinence score*‡                                           3.3 (2)                1.3 (0.8) 
At the last follow up (mean, mo)                                    33.4+1.3 SEM     33.5+1.5 SEM 
Bowel movements*‡                                                       2.6 (0.8)               2.2 (0.5) 
Wexner incontinence score*‡                                           1.0 (1)                1.1 (0.8) 
No statistically significant differences between LAR and LPT patients using the Mann-Whitney U test. *Values are 
in n (percentage). †Visual analog scale with 0 minimum 10 maximum used. ‡Assessed after ileostomy closure at 
the last follow-up. 
 
A repeat CT scan confirmed resolution of the collections. One LPT patient had a drain left in 
for 7 days for persistent blood stained serous discharge, but small bowel contents appeared. 
Gastrografin studies confirmed a small bowel fistula, which closed after 1 week of total 
parental nutrition. Late complications were found in 2 LAR patients, with incisional hernias at 
the ileostomy closure site, who subsequently underwent laparoscopic hernia mesh repair. All 
patients were routinely asked about genitourinary function at the follow-up; 1 LAR patient 
who also underwent postoperative chemoradiotherapy had persistent impotence that had 
not been present before surgery.  
      The mean follow-up was 33.4+1.3 months SEM in the LAR patients and 33.5+1.5 
months SEM in the LPT (P=not significant). Two LPT patients developed liver metastases 3 
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and 18 months after surgery. There were no patients to date with any local recurrences 
detected. 
 
Table 4 Postoperative complications 
                                                                                    LAR (n=21)        LPT (n=19) 
Medical complications 
 Cerebrovascular accident and death                  0 (0)                  1 (5.3)                                                  
 Chest infection                                                  1 (4.8)               2 (10.5) 
 Urinary tract infection                                        2 (9.5)                 0 (0) 
Surgical complications 
 Anastomotic stricture*                                        0 (0)                 4 (21.0) 
 Intra-abdominal collection                                1 (4.8)                1 (4.8) 
 Impotence                                                        1 (5.3)                  0 (0) 
 Drain erosion to bowel                                       0 (0)                  1 (4.8) 
 Incisional hernia                                               2 (9.5)                  0 (0) 
Values are in n (percentage of complication over the number of patients in the group). *P0.042, statistical 
significance was tested using the Mann-Whitney U or Fischer exact test where appropriate. 
 
 
Comments 
      Laparoscopic surgery for rectal cancer can be associated with relatively high morbidity 
and conversion rates, especially when TME with sphincter preservation is performed (12, 16, 
22, 23). Because of these technical difficulties, reports on laparoscopic rectal cancer surgery 
are scanty compared with laparoscopic colon surgery. However, the technique has been 
gradually refined and proven to be feasible (16, 24, 25). Most series reporting on the short-
term and long-term outcome for laparoscopic rectal cancer surgery have included patients 
who underwent laparoscopic high anterior resection and laparoscopic abdominoperineal 
resection. Our results including operative time, blood loss, conversion rate, and 
postoperative complications were comparable to those previously published (Tables 5 and 
6). Most complications were medically related to high-risk elderly patients.  
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      In our study, neither LAR nor LPT offered any technical advantage over the other as 
measured by operative time, blood loss, conversion rate, and overall complications. The 
patient and cancer characteristics were not significantly different between the 2 groups, 
particularly the tumor site. There were more T3 lesions in the LPT group (68.4% vs 47.6%), 
but these were relatively early non-bulky T3 lesions and the tumor size was comparable 
between groups. In addition, more patients in the LAR patients had neoadjuvant therapy, 
and, hence, the postoperative specimens were likely downgraded. LPT did not result in less 
pain although a smaller port was used and the specimen was extracted from the anus 
probably because an abdominal incision was still required for the defunctioning ileostomy. 
Another explanation for this might be our technique of extracting the specimen through the 
protected eventual ileostomy site in the LAR group, (25) which was also likely to have 
reduced postoperative pain by saving on the abdominal incisions made. In addition, the 
routine use of perioperative epidural analgesia in all patients after laparoscopic surgery 
would have significantly reduced postoperative discomfort (31). Sonoda et al. (32) reported 
no significant difference between those who underwent standard laparoscopic surgery 
versus hand-assisted surgery where obviously more incision-length differences were 
compared. The creation of ileostomy with coloanal anastomosis is supported by a recent 
meta-analysis that confirms that a diverting stoma reduces the risks of anastomotic 
dehiscence complications (33).  
Table 5 Laparoscopic low anterior resection: operative times and blood loss reported 
                                                             N         Operative time (h)         Blood loss (mL) 
Chen, et al. (20)                                    8                  3.5                              250 
Selvindos et al. (13)                             55                 3.0                              53.5 
Tjandra, et al. (12)                                31                 3.0                              153 
Palanivelu, et al. (26)                           170                2.3                               40 
Present series                                       40                 2.8                              62.2 
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      Fecal incontinence is more likely in patients with a resection less than 6 to 8 cm from the 
anal verge, often a part of anterior resection syndrome, which has multifactorial causes (34) 
such as loss of the rectal reservoir, iatrogenic injuries of the anal sphincter, (35) or damage 
to autonomic nerve (36). Chemoradiation (37) and/or pelvic floor disease before surgery (31) 
may also play a role. Its incidence has been reported in up to 60% of such patients (38). Our 
series is the first to compare the functional outcome between LPT and LAR. Even though the 
specimen extraction and hand-sewn anastomosis were performed through the anal sphincter 
in LPT patients, there is no significant difference in functional outcome compared with LAR 
patients although the numbers are relatively small. This might possibly be related to the anal 
procedure performed with gentle, minimal, and intermittent dilatation (39).  
Table 6 Outcomes parameter: postoperative conversion rate and complication 
                                                            N       Conversion rate (%)    Complication* (%) 
Laurent, et al. (18)                             117                25                             15.5 
Selvindos, et al. (12)                           55                  5                               8.0 
Tjandra, et al. (11)                               31                  0                              25.8 
Palanivelu, et al. (26)                          170                 0                              13.5 
Leroy, et al. (27)                                  102                 3                               27.0 
Barlehner, et al. (28)                           145                  1                              18.6 
Morino and Giraudo (29)                      98               18.4                             18.4 
Scheidbach, et al. (30)                         231               6.1                             37.6 
Dulucq, et al. (24)                                218               12                               21.0 
Present series                                      40                7.5                              27.5 
*Overall complications are the percentage of the patients with complications because some complications 
occurred in the same patients and were probably related. This was also the method of reporting in the other 
series. 
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      We decided to use the adequately validated Wexner incontinence score for functional 
evaluation in this study because of its unique correlation with clinical evaluation, 
reproducibility, and sensitivity to change produced by definitive treatment. It is also the first 
easy-to-use incontinence scoring system to take into account usage of pads and lifestyle 
alteration as well as the consistency and frequency of incontinence (21). Electrophysiologic 
studies are generally not well correlated with clinical function especially with relatively small 
numbers of patients and therefore not being used (or prescribed) routinely as an 
investigation. It was selectively used in some cases (31). 
      In conventional open surgery, the coloanal pull-through hand-sewn anastomosis for 
rectal cancer (40) had become less commonly performed after the evolution of the stapling 
devices, which routinely enable distal rectal anastomosis deep in the pelvis. Nonetheless, it 
continues to have a role when the pelvis is narrow, the forward angle of distal rectum and 
when the rectal cancer is very distal particularly with intersphincteric resection (20, 41, 42). 
Laparoscopic rectal cancer surgery is hampered by inadequate articulation of endoscopic 
staplers for distal rectal transection near the level of the anorectal ring. This might result in a 
long oblique stapler line on the anorectal stump, which requires multiple applications of the 
stapler compromising adequate distal margin or anastomotic integrity. Another challenge of 
both laparoscopic and open surgery is that the distal tumor margin may not always be 
correctly identified. The bulk of the mesorectum may obscure the precise localization of the 
tumor; moreover, obtaining a reliable distal margin may be even more difficult in patients 
who have undergone neoadjuvant chemoradiotherapy, because the residual tumor may be 
small or absent (43). LPT may be used routinely to overcome these technical difficulties, (44) 
but theoretic concerns with wound contamination from specimen extraction remain although 
this is not proven with results available to date. However, we found in this study and with 
previous experience that LAR is usually possible without excessive problems after incision of 
Waldeyer’s fascia (27). The latter step can be easily performed laparoscopically with 
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inversion of the 30° camera in the pelvis, allowing the rectum to be brought proximally and 
forward to facilitate stapler transaction (45). It is likely that improvements in stapler 
technology including the powered staplers may further assist this (46). 
    Four patients all in the LPT group developed severe anastomotic strictures after the 
completion of radiochemotherapy. Previously reported factors that may be associated with 
anastomotic stricture include ischemia, anastomotic dehiscence, (47–49) obesity, pelvic 
sepsis, radiotherapy, and diverting proximal ostomy (50, 51). The late strictures found in our 
study were significantly related to the effect of postoperative radiotherapy. Hence, it is 
suggested that LAR be the routinely preferred technique particularly if the patient is likely to 
have chemotherapy radiotherapy. LPT could be considered as when a hand-sewn coloanal 
anastomosis is indicated for open surgery that is when difficulties are encountered with distal 
bulky tumors in patients with narrow tight pelvis.  
      The limitations of this study include the relatively small sample size and the medium not 
long-term follow-up particularly addressing oncologic issues. Planned randomized controlled 
trials addressing this issue with a larger sample size and long-term follow-up should be 
performed to consider the possible higher risk of delayed anastomotic structuring after LPT.  
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Chapter 4:  Factors influencing rectal cancer treatment 
outcomes 
 
Overview 
      Circumferential resection margin has been considered and repeatedly reported as one of 
the most important factors in locoregional control of rectal cancer treatment. This chapter 
contains the relevant data on factors considered to influence circumferential resection 
margin positivity during rectal cancer surgery. High-quality TME with negative circumferential 
resection margin will certainly lead to longer disease-free survival and overall survival.  
 
Factors Influencing Circumferential Resection Margin in 
Rectal Cancer.  
(Colorectal Dis. 2013; 15(3): 298-303) 
BACKGROUND: Abdominoperineal excision (APR) has been associated with higher 
circumferential resection margin (CRM) involvement and local recurrence rates than 
extralevator APR for low rectal cancer. This study aimed to evaluate the CRMs in APR 
and low anterior resection (LAR) specimens and to identify factors influencing CRM 
involvement. METHOD: All pathological specimens from consecutive patients with 
rectal cancer who underwent curative resection at the Cleveland Clinic Florida, from 
January 2000 to July 2010, were reviewed by two pathologists. Demographics, tumour 
characteristics, operative data, postoperative pathology and Dworak’s tumour 
regression grade were compared between specimens with positive and negative 
CRMs. RESULTS: One-hundred and fifty-four patients underwent curative APR (n=65) 
or LAR (n=69). Mean tumour size was 3.6 cm, and mean distance from the dentate line 
was 5.4 cm. Nine (6.8%) patients had a positive CRM (n=6 APR, n=3 LAR), which was 
associated with tumour size > 5.9 cm (P= 0.002), a distance of £2.6 cm from the 
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dentate line (P= 0.013), microvascular invasion (P= 0.009), perineural invasion (P< 
0.001), number of positive lymph nodes (P= 0.046) and incomplete total mesorectal 
excision (TME) (P< 0.001). APR specimens were three times more likely than LAR 
specimens to have an incomplete mesorectum (9.8% vs 2.9%, P= 0.322). 
CONCLUSIONS: Factors associated with a positive CRM were tumour size > 5.9 cm, a 
distance of £2.6 cm from the dentate line, incomplete TME, number of positive nodes 
and microvascular and perineural invasion. The incidence of a positive CRM was not 
significantly different between LAR and APR (n= 3 LAR and n=6 APR).  
 
      The adequacy of local control is an essential goal in the treatment of rectal cancer. The 
introduction of advances in rectal cancer surgery, such as total mesorectal excision (TME), 
which provides complete resection of the tumour together with its lymphatic and venous 
drainage (1,2), and neoadjuvant chemoradiotherapy have drastically reduced the reported 
rates of local recurrence (3, 4). Interestingly, the improvement in overall treatment outcomes 
of distal rectal cancer has not reached the same level as obtained for mid or proximal lesions 
(5). Specifically, a higher rate of suboptimal circumferential resection margins (CRMs) has 
been found in patients undergoing abdominoperineal excision (APR) when compared with 
patients undergoing anterior resection (41% vs 12%). This CRM-positivity rate has, at least 
in part, led to higher local recurrence (36.5% vs 22.3%) and lower survival (52.3% vs 
65.8%). In addition, CRM status has been reported to be a strong prognosticator for local 
and distant recurrence and for survival (6). 
      A better understanding of the factors influencing CRM positivity is important and will help 
in the design of risk-adapted treatment of rectal cancer patients. The purpose of this study 
was to analyze the CRMs in APR and low anterior resection (LAR) specimens and to identify 
factors influencing CRM involvement.  
 
73 
 
Method 
      After Institutional Review Board approval, patients at the Cleveland Clinic Florida who 
had a primary diagnosis of adenocarcinoma of the rectum and underwent curative LAR or 
APR from January 2000 to July 2010 were identified from a prospectively collected 
colorectal surgery database. Patients with a pT4tumour, Stage IV disease, and those who 
had had a complete pathological response (ypT0N0) were excluded. Pathological specimens 
were reviewed by two experienced gastrointestinal pathologists. The patients’ 
demographics, tumour characteristics, operative data, postoperative pathology, quality of 
total mesorectal excision (2) and Dworak’s tumour regression grade (TRG) (7) were 
compared between specimens with a positive and a negative CRM. Pathological staging 
was performed using the International Union Against Cancer TNM system, fifth edition (8). 
CRM involvement was defined as the presence of tumour cells located 1 mm or less from 
the painted resection margin, as determined by microscopic evaluation. 
 
Neoadjuvant therapy 
      Neoadjuvant chemoradiotherapy was administered to all T3 or N-positive mid- and low 
rectal adenocarcinomas evaluated by endorectal ultrasound and⁄ or MRI. Radiotherapy was 
given over 5–6 weeks with a total dose of 45 Gy to the pelvis and a boost to the rectum to a 
total of 50.4 Gy over 28 fractions. 5-Fluorouracil was administered concurrently as a 
continuous infusion of 225 mg⁄ m2 per day. Standard TME (9) was performed 6–8 weeks 
after chemoradiotherapy in the supine modified lithotomy position in all cases. 
 
Statistical analysis 
      Statistical analyses were performed using Fisher’s exact test, the Mann–Whitney U-test, 
the log-likelihood ratio test or the Student’s t-test, as appropriate. The log likelihood ratio x2 
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test was applied in the special situation in which there was no relationship between the two 
categorical variables and the expected value in any cell of a contingency table was <5. 
P<0.05 was considered statistically significant. 
 
Results 
      After the exclusion of pT4 and Stage IV patients, 154 patients who underwent curative 
APR or LAR for midrectal cancer between January 2000 and July 2010 were identified. 
Ninety-three patients (59%) received neoadjuvant chemoradiotherapy. Twenty (18%) of 
these patients had a histopathological complete response and were excluded from the study. 
From a total of 134 patients, 65 underwent APR and 69 underwent LAR. The mean tumour 
size was 3.6 cm, and the mean distance from the dentate line was 5.4 cm. Nine (6.8%) 
patients had a positive CRM (n=6 APR, n=3 LAR), and 125 (94%) patients had a negative 
CRM (n=59 APR, n=66 LAR). There was no significant difference in the age, gender, body 
mass index (BMI), type of surgery, type of procedure, site of tumour, tumour location and 
use of neoadjuvant chemoradiotherapy between the positive and negative CRM groups 
(Table 1).  
      The mean operative time was 214.4+71.3 min (positive CRM group) vs 203.7+70.5 min 
(negative CRM group), and estimated blood loss was 283.3+163.3 ml (positive CRM group) 
vs 334.1+335.1 ml (negative CRM group); there was no significant difference between the 
groups, suggesting no difference in the degree of technical difficulty during TME (Table 2). 
Pathological stage did not vary significantly between the two groups. The number of 
harvested lymph nodes (27.9+13.4, positive CRM group vs 21.613.6, negative CRM group; 
P= 0.108) and Dworak’s TRG were similar in both cohorts (Table 3). Intra-operative tumour 
perforation was not found in any specimen, and the distal resection margin was free of 
tumour in all patients. 
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Table 1 Patients’ demographic data 
                                                                CRM   
                                                             Positive(n=9)       Negative(n=125)      P-value 
                                                                  (6.8%)                    (93.2%) 
Age (years)                                              68+18.2                   62+14.1                0.280* 
Gender                                                                                                                  0.483+ 
 Male                                             7 (77.8)                  77 (61.6)                  
 Female                                         2 (22.2)                  48 (38.4) 
ASA                                                             2                              2                        0.886‡ 
Obesity                                                                                                                  0.446 
 BMI<30kg⁄ m2                                8 (88.9)                 91 (72.8)                  
 BMI>30 kg⁄ m2                               1 (11.1)                 34 (27.2) 
Neoadjuvant chemoradiotherapy                                                                           0.184+ 
 Yes                                               3 (33.3)                   72 (57.6)                 
 No                                                 6 (66.7)                   53 (42.4) 
Type of surgery                                                                                                       0.701+ 
 Laparoscopic                                3 (33.3)                    33 (26.4)           
 Open                                             6 (66.7)                    92 (73.6) 
Type of procedure                                                                                                   0.315+ 
 APR                                              6 (66.7)                    59 (47.2)           
 LAR                                              3 (33.3)                    66 (52.8) 
 
Tumour site (mm)                                    44.7+46.6                 54.8+38.2                0.171‡ 
(level from anal verge) 
Tumour location                                                                                                        1.000+ 
 Anterior                                          1 (14.3)                      18 (24)              
 Others                                            6 (85.7)                      57 (76) 
Values are given as median, mean+SD or n(%). APR, abdominoperineal resection; ASA, American Society of 
Anesthesiology; BMI, body mass index; CRM, circumferential margin; LAR, low anterior resection. *Student’s t-
test. +Fisher’s exact test. ‡Mann–Whitney U-test 
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       The study demonstrated a significant association between CRM positivity and tumour 
size > 5.9 cm (P= 0.002), a distance of < 2.6 cm from the dentate line (P= 0.013), incomplete 
TME (P< 0.001) and a greater number of positive lymph nodes (P= 0.046; Table 3). In 
addition, the presence of an incomplete mesorectum was three times higher in APR 
specimens compared with LAR specimens (9.8%vs2.9%); nevertheless, this finding did not 
reach statistical significance. There was a significant correlation between positive CRM and 
both microvascular invasion (P=0.010) and perineural invasion (P= 0.009), while no 
association was seen with tumour grade, mucin production, lymphatic invasion and the 
presence of signet ring cell (Table 4). 
 
Table 2 Operative outcome 
                                                                                             CRM 
                                                                                Positive             Negative         P-value 
                                                                                   (n=9)                 (n=125) 
Operative time (min)                                               214.4+71.3     203.7+70.5       0.575* 
Operative blood loss (ml)                                       283.3+163.3   334.1+335.1     0.984* 
Postoperative stage                                                                                                0.020+,** 
 Stage I                                                                0                45 (36.3)         
 Stage II                                                           3 (33.3)          28 (22.6) 
 Stage III                                                          6 (66.7)          51 (41.1) 
Values are given as mean+SD or n(%). CRM, circumferential margin. *Mann–WhitneyU-test. +Log likelihood ratio 
test. **Statistically significant. 
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Discussion 
      The study has shown a significant association for CRM positivity in rectal cancer 
specimens with tumour size (P= 0.002), distance of the tumour from the dentate line (P= 
0.013), presence of lymph node metastasis (P= 0.046), microvascular invasion (P= 0.009), 
perineural invasion (P<0.001) and an incomplete mesorectum (P= 0.018). Well-performed 
TMEs with a resection margin at the mesorectal plane had a lower CRM positivity rate than 
did specimens in which an incomplete TME had been performed (10, 11). 
 
Table 3 Pathological parameter and tumour staging 
                                                                                        CRM 
                                                                           Positive          Negative         P-value 
                                                                              (n=9)            (n=125) 
T stage                                                                                                                0.005*,** 
 T1                                                                 0                 15 (12)        
 T2                                                                 0                42 (33.6) 
 T3                                                            9 (100)            68 (54.4) 
Nodal stage                                                                                                          0.046*,** 
 N0                                                            3 (33.3)            72 (57.6)       
 N1                                                            2 (22.2)             40 (32) 
 N2                                                            4 (44.4)            13 (10.4) 
Tumour size (mm)                                              59.2+22.6         34.7+19.6          0.002+,** 
Number of harvested                                          27.9+13.4          21.6+3.6           0.108+ 
lymph nodes     
TRG (Dworak)                                                                                                        1.000‡ 
 Grade 1–2                                                    1 (33.3)             29 (40)        
 Grade 3–5                                                    2 (66.7)             43 (60) 
TME quality                                                                                                          < 0.001‡,** 
 Complete                                                      3 (33.3)           98 (94.5)    
 Incomplete                                                    6 (66.7)             6 (5.5) 
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Table 3 Pathological parameter and tumour staging (continued) 
                                                                                           CRM 
                                                                              Positive          Negative         P-value 
                                                                                 (n=9)            (n=125) 
Tumour distance from dentate line                                                                      0.013‡,** 
 <26 mm                                                      6 (66.7)          28 (24.3)       
 > 26 mm                                                     3 (33.3)          87 (75.7) 
Values are given as mean+SD or n(%). CRM, circumferential margin; TME, total mesorectal excision; TRG, 
tumour regression grade. *Log-likelihood ratio test. +Mann-Whitney U-test. ‡Fisher’s exact test. **Statistically 
significant. 
 
 
      The reported incidence of CRM positivity between mid and low rectal cancer varies 
from 8% to 41% (5, 12, 13). Our finding of an overall CRM involvement of 6% appeared to 
be low when compared with other published rates. Such a difference could perhaps be 
explained by the different methodology and⁄ or study design, including neoadjuvant regimen, 
the exclusion of T4 lesions, as well as surgical approach. The fact that all surgery in our 
study was performed by highly experienced specialized colorectal surgeons might be an 
important factor contributing to this better outcome. Similarly to other studies (5, 12, 14), a 
significant correlation between CRM positivity and tumour location <2.6 cm from the dentate 
line (P=0.014) was also demonstrated. Moreover, we found that CRM involvement was twice 
as common in the APR group as in the LAR group (66.7% vs 33%). Similarly, other studies 
have found higher CRM positivity and intra-operative perforation rates in patients who 
underwent APR compared with patients who underwent LAR (5, 12, 14–17). Guillou et al. 
(17) performed a multicenter randomized controlled trial in 794 patients with colorectal 
cancer in 27 UK centres. Overall, rectal cancer patients who underwent APR demonstrated 
a two-fold increased incidence of CRM involvement when compared with patients who 
underwent anterior resection (20 (23%) of 75 vs17 (10%) of 193). From a multicentre study 
of 1036 rectal cancer patients, Tekkis et al. (16) found that those who underwent APR 
showed significantly higher CRM positivity compared with patients who had anterior 
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resection (16.7% vs 7.5%, P< 0.001). The authors concluded that surgical technique with 
wide perineal dissection and the use of neoadjuvant therapy may reduce CRM involvement 
in patients with rectal cancer following APR. It is therefore also notable that there were no 
tumour perforations and a CRM positivity rate of only 10.8% achieved in the supine modified 
lithotomy position. These findings are in sharp contrast to the reports by Holm, West and 
Quirke, who propose that such low CRM positivity rates can only be achieved in the prone 
jack-knife position. However, Lavery and coworkers have recently refuted this claim, citing 
findings similar to those results reported in the current study (18). Nagtegaal et al. (6) 
suggested that the main causes of CRM positivity may be related to suboptimal surgical 
technique and to the special anatomy of the lower rectum and anal canal. This is 
characterized by a reduction in the volume of mesorectal tissue when following the 
mesorectal plane to the anorectal junction. This fact may be responsible for less extrarectal 
tissue around a low-lying tumour, leading to an increase in the likelihood of CRM 
involvement and of intra-operative perforation (5). Similarly to the original Miles’ procedure 
(19), extralevator APR has recently been introduced to reduce the rates of CRM involvement 
and intra-operative perforation found with ‘standard’ APR (20, 21). Extralevator APR, which 
was proposed by Holm et al. (21)  
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Table 4 Histological characteristics 
                                                                        CRM 
                                                                 Positive          Negative         P-value 
                                                                   (n=9)             (n=125)  
Tumour grade                                                                                           0.620* 
 Low grade                                         6 (75)            93 (83.8)            
 High grade                                        2 (25)            18 (16.2) 
Mucin                                                                                                       0.168* 
 Positive                                            3 (33.3)          18 (15.3)             
 Negative                                          6 (66.7)         100 (84.7) 
Lymphatic invasion                                                                                    0.178* 
 Positive                                           3 (37.5)           22 (17.9)             
 Negative                                         5 (62.5)          101 (82.1) 
Microvascular invasion                                                                               0.009*,** 
 Positive                                           6 (66.7)            28 (22.8)         
 Negative                                          3 (33.3)            95 (77.2) 
Signet ring cell                                                                                           0.174* 
 Positive                                          1 (12.5)                2 (1.6)             
 Negative                                         7 (87.5)             121 (98.4) 
Perineural invasion                                                                              < 0.001*,** 
 Positive                                           6 (66.7)            15 (12.2)       
 Negative                                         3 (33.3)           108 (87.8) 
Values are given as mean+SD or n(%). CRM, circumferential margin. *Fisher’s exact test. **Statistically 
significant. 
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in 2007, demonstrated the important modification of not dissecting the mesorectum from 
the levator muscle. It is recommended that the rectum should be mobilized from the 
abdomen until the seminal vesicles in men and upper vagina in women. For better 
exposure and visualization, the authors preferred a prone jack-knife position for the 
perineal part of the operation. The dissection was continued just outside the 
subcutaneous portion of the external anal sphincter; the levator muscle was then 
identified. The dissection was continued along the outer surface of the levator muscles 
proximally until the insertion onto the pelvic side wall. Furthermore, the coccyx excision 
should be done to facilitate visualization of the posterior pelvis previously dissected 
through the abdomen. More recently, West et al. (20) confirmed that extralevator APR in 
the prone position removes more tissue around the tumor and leads to a reduction in 
circumferential resection margin involvement and intraoperative perforations. This 
concept has, however, been challenged by authors who practice meticulous standard 
APR surgery with outcomes equivalent to those following anterior resection (22, 23). 
      Several tumour-related factors have been correlated with CRM positivity. Advanced 
TNM stage had an obvious relationship with a higher possibility of CRM involvement (2, 
10, 15, 16, 24–26). Other than direct tumour extension, involvement of the CRM may 
occur as a result of the presence of metastatic lymph node, foci of microvascular 
invasion or tumour budding. 
      Our results demonstrated a significant correlation between a positive CRM and an 
increased number of involved lymph nodes (P=0.031); however, the depth of tumour 
invasion (T stage) did not impact CRM involvement. This finding might be explained by 
the exclusion of T4 lesions and careful patient selection for neoadjuvant therapy. Larger 
tumours, and lesions with an ulcerative or a stenosing growth pattern, correlated with a 
higher likelihood of a positive CRM (24). The present study demonstrated a significant 
association between tumours larger than 5.9 cm and CRM involvement (P= 0.002). 
82 
 
      In the current study, microvascular (P= 0.009) and perineural (P< 0.001) invasion 
were significantly related to an involved CRM. Similar findings have been previously 
reported in other studies (27, 28). In addition, many authors showed that a positive CRM 
is significantly associated with an infiltrating margin [2] and poor histological 
differentiation (2, 27, 28). Ueno et al. (27) showed that poor differentiation in submucosal 
transanal biopsies was predictive for CRM involvement (OR = 10.8; 95% CI, 1.7–67.1), 
as was microvascular invasion (OR = 16.1; 95% CI, 1.9–139.2). 
      We acknowledge that this study had low statistical power owing to the low numbers 
of CRM events. Moreover, because it was a retrospective study, some preoperative 
factors, such as pre-neoadjuvant tumour characteristics, which might be directly related 
to CRM positivity, were not analysed. Despite these limitations, we were able to identify 
tumour-related factors associated with a positive CRM, which could potentially impact on 
surgical planning for the achievement of a negative CRM and consequently improve 
patients’ outcomes. 
      Despite the limitation of the low number of patients with a positive CRM, significant 
associations between CRM positivity and tumour size > 5.9 cm, a distance £2.6 cm from 
the dentate line, incomplete TME, number of positive nodes, and microvascular and 
perineural invasion were identified. The incidence of a positive CRM did not differ 
significantly between LAR and APR; however, an incomplete mesorectum was more 
commonly seen following APR, suggesting an inadequate plane of dissection with this 
technique. Furthermore, an overall CRM positivity rate of 6.8% has been achieved with 
routine use of the modified lithotomy position. 
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Chapter 5: Technique to avoid postsurgical complication 
 
Overview 
      It has been criticized for the necessity of high ligation of inferior mesenteric vessels 
and splenic flexure take down during rectal resection with anastomosis. The direct 
experience working in tertiary referral center had brought up the question of how to avoid 
this difficult to treat postoperative complication, anastomosis stricture. The detail of this 
published data can guide the colorectal surgeons to carefully consider these additional 
steps to prevent re-surgery. The tips can certainly be applied to rectal cancer patients for 
uneventful recovery and better quality of live.     
 
Colorectal Anastomotic Stricture: Is it associated with 
inadequate Colonic Mobilization?  
(Tech Coloproctol. 2013 ;17(4):371-5) 
BACKGROUND: Anastomotic stricture or stenosis is a well described 
complication of intestinal anastomosis. The incidence of stricture after colorectal 
anastomosis ranges from 0 to 30 %. The aim of this study was to identify possible 
factors related to postoperative colorectal anastomotic stricture and to indicate 
reoperative surgery outcomes. METHODS: After institutional review board 
approval, medical records were reviewed for patients who underwent surgery for 
colorectal anastomotic stricture at Cleveland Clinic Florida between January 2001 
and December 2010. The main outcome measures were demographics, indications 
for initial surgery, body mass index, comorbidities, previous treatment, level of 
anastomosis, history of radiotherapy, and operative data for the reoperative 
surgery. RESULTS: Nineteen patients (15 males) were eligible for the study. Nine 
patients had a diagnosis of cancer, 7 of whom received radiotherapy. The initial 
surgeries were low anterior resection (n=9; 47.4 %), high anterior resection (n=9; 
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47.4 %), and sigmoidectomy (n=1; 5.2 %). Six patients (31.6 %) had anastomotic 
leak after initial surgery. The majority of the patients (n=17; 89.5 %) had an intact 
splenic flexure, inferior mesenteric artery, and inferior mesenteric vein. In all 
patients, full mobilization of the splenic flexure and high ligation of the mesenteric 
vessels was performed. Seven patients (36 %) developed postoperative 
complications. Over a mean follow-up of 24.3 months, there was no recurrence of 
anastomotic stricture. CONCLUSIONS: An intact splenic flexure and mesenteric 
vessels were the most prevalent in patients who underwent reoperation at our 
institution. Full mobilization of the splenic flexure, high ligation of the mesenteric 
vessels, anastomotic stricture resection, and re-anastomosis can be successfully 
performed with satisfactory outcomes.  
 
      The incidence of stricture after colorectal anastomosis ranges from 0 to 30 %, 
although only 5 % of patients become symptomatic (1–11). The heterogeneous surgical 
indications, types of surgical and anastomotic procedures, and definitions of anastomotic 
stricture may explain the wide range in incidence. Although strictures are thought to be 
related to various factors, including radiation (12), anastomotic ischemia or leak (13, 14), 
or technique (7, 15, 16), there is a lack of adequate information regarding the etiology of 
stricture formation and its risk factors. The aim of this study was to identify possible 
factors related to postoperative colorectal anastomotic stricture and reoperative surgery 
outcomes.  
 
 
 
 
89 
 
Methods 
      The medical records of all patients who underwent surgical resection for a colorectal 
anastomotic stricture at Cleveland Clinic Florida between January 2001 and December 
2010 were reviewed after institutional review board (IRB) approval. Anastomotic stricture 
was defined as the inability to freely pass a 12-mm sigmoidoscope through the 
anastomosis in a patient with symptoms including left iliac fossa pain when passing stool 
and/or gas, abdominal distention, fractionated evacuation, constipation, and/or when thin 
stools were noted. Other causes of anastomotic stricture such as malignancy, 
inflammatory bowel disease, and diverticulitis were excluded. Patient demographics, 
indications for initial surgery, body mass index (BMI), comorbidities, previous treatments 
for anastomotic stricture, distance of anastomosis from the dentate line, history of 
radiotherapy, operative data, and functional outcomes were collected. Obesity was 
defined as BMI > 30 kg/m2 (17). 
 
Surgical technique 
      All patients without ileostomies underwent mechanical colonic preparation. Antibiotic 
prophylaxis was administered within 1 h prior to the incision. Intraoperative bilateral 
ureteric catheters were utilized in all cases.  
      The proximal colon was mobilized by freeing the left colon and splenic flexure from 
the peritoneal attachments and dividing the inferior mesenteric artery (IMA) at its origin 
from the aorta and the inferior mesenteric vein (IMV) at the lower border of the pancreas. 
The strictured anastomosis was resected, and a redo tension-free colorectal 
anastomosis was performed using double-stapled technique or hand-sewn coloanal 
anastomosis. A 33-mm circular stapler was routinely used to perform stapled 
anastomosis. Subsequent intraoperative endoscopic assessment of the anastomosis 
was routinely performed to ensure continuity of the anastomosis, mucosal viability, and 
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anastomotic hemostasis. If not already presented, temporary loop ileostomy was 
performed in patients in whom the anastomosis was created within 4 cm from the anal 
verge.  
 
Results  
      Nineteen patients, including 15 males and 4 females of a mean age of 59 years (SD 
11.6; range 29–78 years), were treated for postoperative anastomotic stricture. 
Seventeen (89.5 %) patients had the initial surgery performed at other hospitals and 
were subsequently referred to our institution for treatment. The majority were non-
smokers (n=8; 42.1 %) or ex-smokers (n=8; 42.1 %); and 3 (15.8 %) were smokers. The 
mean BMI was 26.5 kg/m2 (SD 4.4; range 13.5–34.2 kg/m2). Four patients (21.1 %) were 
obese. Twelve patients (63.2 %) had comorbidities, including cardiac problems (n=5; 
41.7 %), hypertension (n=4; 33.3 %), diabetes (n=2; 16.7 %), and renal problems (n=1; 
8.3 %). The mean American Society of Anesthesiologists (ASA) score was 2. 
 
Initial surgery 
      The indications for the index surgery were rectal cancer (n=9; 47.4 %), diverticulitis 
(n=9; 47.4 %), and a gunshot wound (n=1; 5.2 %). Among the patients with rectal 
cancer, 7 (77.8 %) underwent radiotherapy, 4 (57.1 %) preoperatively, and 3 (42.9 %) 
postoperatively. The initial procedures included low anterior resection (n=9; 47.4 %), high 
anterior resection (n=9; 47.4 %), and sigmoidectomy (n=1; 5.2 %). Seventeen of the 
surgeries were performed by open laparotomy, 1 by laparoscopy, and 1 hand-assisted. 
None of the 19 operative reports included specific information about high IMA and IMV 
ligation or splenic flexure mobilization. The mean distance of the anastomosis from the 
dentate line was 11.9 cm (SD 7.5; range 0–25 cm). Most of the original anastomoses 
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were located within 20 cm from the dentate line. Only 1 patient who underwent 
sigmoidectomy for acute diverticulitis had an anastomosis 25 cm from the dentate line. 
There were 6 anastomotic leaks, 3 of which were successfully treated with bowel rest, 
percutaneous drainage, total parenteral nutrition, and intravenous antibiotics. Fecal 
diversion was required in the other 3 patients. Attempts at endoscopic balloon dilations 
of the strictured anastomosis were performed in 7 patients (36.8 %), resulting in 1 
perforation of a strictured anastomosis 6 cm cephalad to the dentate line. One patient 
failed multiple anastomotic dilatations using Hegar dilators.  
 
Reoperative surgery  
      The mean time to the reoperative surgery was 14.3 months (SD 10.9; range 4–48 
months). The procedures included anterior resection in 18 patients (94.7 %) and 
abdominoperineal resection (APR) in 1 patient (5.3 %). The latter operation was 
performed in a rectal cancer patient who had initially undergone a low anterior resection 
and postoperative radiotherapy. A nonfunctioning fibrotic anal sphincter together with a 
severe anastomotic stricture precluded restorative surgery. Sixteen anastomoses were 
performed using the double-stapled technique, while hand-sewn coloanal anastomosis 
was undertaken in 2 patients. The mean distance of the new anastomosis was 4.5 cm 
from the dentate line. In 17 patients (89.5 %), neither the splenic flexure nor the IMA or 
IMV had been mobilized and divided at the time of the index procedures. Only 2 patients 
(12.5 %) with rectal cancer had the splenic flexure mobilized along with the high division 
of the mesenteric vessels. The levels of these anastomoses were at 4 and 5 cm from the 
dentate line, respectively. Colonic J-pouches were fashioned in 5 patients. The mean 
operative time was 232.8 min (SD 68.3; range 50–360 min), and the mean operative 
blood loss was 250 mL (SD 70; range 100–1,500 mL). A temporary loop ileostomy was 
performed in 11 patients (57.9 %). No intraoperative complications occurred. 
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Postoperative complications were observed in 7 patients (36.8 %), including wound 
infection, wound dehiscence, pulmonary embolism, urinary retention, pneumonia, ileus, 
and myocardial infarction. There were no anastomotic complications or mortality. The 
mean hospital stay was 12.1 days (SD 8.5; range 4–34 days). The mean time until loop 
ileostomy reversal was 3.6 months. No recurrent stricture occurred at a mean follow-up 
of 24.3 months, and all 18 patients were continent; 2 patients reported urgency (11.1 %), 
and 4 patients (22.2 %) had more than 3 bowel movements per day.  
 
Discussion 
      Despite the unclear pathophysiology of anastomotic stricture (1, 12), multiple 
techniques have been used for its management, including staplers and cutting devices 
(18), steroid injections (19), the combined use of electrocautery and photoablation (20–
22), manual or instrumental dilatation using a balloon, bougie, or pneumatic dilator (23–
28), and surgical resection and re-anastomosis (12, 29). Similar to other reported studies 
(12, 29), our study demonstrated that the rectum was the most common site of stricture. 
In this study, the most common treatment prior to surgical intervention was endoscopic 
balloon dilatation (7 of the 19 patients; 36.8 %). This simple rapid procedure, with a 
reported success rate of 75 % (23–25, 30), may be adequate for a short anastomotic 
stricture (23, 25). However, if more than 3 sessions are required, this method is likely to 
result in poor bowel function (24).  
      Resection of the stricture site and re-anastomosis are usually performed for long 
segment strictures, following anastomotic leak, radiation therapy, or failure of other 
methods (12, 29, 31). To perform an anastomosis following a distal colorectal resection, 
it is important to have sufficient length of proximal colon to avoid tension at the suture 
line. The current case series found that 17 of the 19 patients (89.5 %) with anastomotic 
stricture had an intact splenic flexure as well as inferior mesenteric vessels. These 
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findings represented the single most important factors related to anastomotic stricture. 
Tension-free anastomosis is facilitated by freeing the left colon and splenic flexure from 
the peritoneal attachments, and dividing the IMA and IMV.  
      Maximal length can be obtained by dividing the IMA at its origin from the aorta, rather 
than below the origin of the left colic artery, together with the division of the IMV at the 
lower border of the pancreas. This ‘‘high tie’’ leaves the colon proximal to the 
anastomosis reliant on the marginal artery and shifts the blood supply from the inferior 
mesenteric axis to the superior mesenteric axis. However, some authors have suggested 
a ‘‘low tie’’ technique, in which the division of IMA is performed below the origin of the left 
colic artery to gain better blood supply to the colon proximal to anastomosis (32). In 
addition, there has been little evidence to support any oncological or survival benefit 
among cancer patients from more radical lymph node clearance using the ‘‘high tie’’ 
technique (33–35).  
      Hall et al. (36) measured tissue oxygen tension proximal to the resection margin 
before and after either low or high division of the IMA in 62 patients who underwent 
elective colorectal resections. Oxygen tension improved when the transverse and 
descending colon were used for anastomosis but diminished for sigmoid anastomosis. 
Changes in oxygenation were significantly affected by the location of the proximal 
resection site but not by choice of high or low tie. The results suggested that the sigmoid 
colon is not suitable for anastomosis; however, the middle colic artery via the marginal 
artery can maintain a viable blood supply to a pelvic anastomosis when the transverse or 
descending colon is used. The authors concluded that the sigmoid colon should be 
sacrificed and there should be no hesitation in performing a high tie and routine splenic 
flexure mobilization for maximal length to avoid tension in low pelvic anastomosis. This 
finding has been confirmed by other authors (37, 38).  
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      Arguments have arisen as to whether the IMA should be divided during operations 
performed for benign disease and, if so, at which level. In a prospective study of elective 
laparoscopic sigmoidectomy for diverticular disease, Ambrosetti et al. (11) found that 
arterial preservation did not prevent anastomotic stricture. Eleven of the 55 patients (20 
%) whose IMA was preserved had anastomotic stenosis compared with 1 of the 13 
patients (7.7 %) whose IMA was not preserved. Similar findings have been also 
described by other authors (18, 39, 40).  
      This study demonstrated that redo-operation with resection of the previous 
anastomosis and colorectal/coloanal anastomosis is feasible and safe. Even though the 
operations tend to be difficult because they are redo procedures and because of 
increased operative times, blood loss, and length of hospital stay, acceptable rates of 
complications and postoperative recovery confirmed the feasibility and safety of the 
procedure.  
      Other risk factors for anastomotic stricture, including anastomotic dehiscence, pelvic 
sepsis, ischemia, inflammatory bowel disease and radiotherapy, have been reported (8, 
12, 41). In our study, 6 of the 19 patients had a clinical anastomotic leak after initial 
surgery, and 31.6 % of these leaks resulted in subsequent stricture. One of the main 
factors associated with anastomotic dehiscence is how far distal the anastomosis is. The 
more distal the anastomosis, the higher is the risk of dehiscence. We observed 11.9 cm 
as the mean distance from the anastomosis to the dentate line. We also found that the 
majority of patients who had anastomotic stricture were male (79 %). This finding is 
perhaps related to the more technical challenge of performing the anastomosis in the 
deep narrow male pelvis. In addition, 7 of the 9 rectal cancer patients (77.8 %) 
underwent either preoperative or postoperative radiotherapy. Four of the 19 patients 
(21.1 %) were obese.  
95 
 
      Furthermore, Law et al. (42) and Rullier et al. (43) demonstrated a higher leak rate 
following stapled anastomosis compared to hand-sewn. They attributed this to the 
difficulty of the cases undergoing stapled astomosis. However, a systematic review of 
nine randomized controlled trials could not find any significant difference in leak rates 
between the two groups (44). 
      This study is limited by a small sample size. In addition, some preoperative factors 
that might be directly related to anastomotic stricture, such as incomplete doughnuts (12) 
and anastomotic technique (16), could not be analyzed due to the fact that all the 
collected data were based solely on the review of medical records. 
 
Conclusions 
      A correlation seems to exist between failure to mobilize the splenic flexure as well as 
failure to divide the IMA and IMV and colorectal anastomotic stricture. Full mobilization of 
the splenic flexure with high division of the IMA and IMV together with resection of the 
stenosis and re-anastomosis can be successfully performed with satisfactory outcomes 
to treat colorectal anastomotic stricture.  
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Chapter 6:  Protocols for rapid recovery 
 
Overview 
      All the surgeons are currently facing surgical correctable health issues among elderly 
population. Colorectal surgeons are also challenged by cancer diagnosed in elderly 
patients. This published review will be helpful in the decision making, patient selection 
and to consider physical age rather than chronological age for adequate plan for 
treatment. Furthermore, the review in management of postoperative ileus in the elderly 
will facilitate the uneventful and rapid recovery for this group of patients.    
 
Epidemiology, Pathophysiology and Medical 
Management of Postoperative Ileus in the Elderly.  
(Drugs Aging. 2011; 28(2):107-18) 
As the population of the Western world ages, the number of major surgical 
procedures performed in the elderly population will by necessity increase. Within 
virtually every surgical specialty, studies have shown that patients should not be 
denied surgery on the basis of chronological age alone. It has recently been 
recognized that physiological age is far more important within the decision-
making algorithm as to whether or not to proceed with major surgery in the 
septuagenarian and octogenarian populations and beyond. Not unexpectedly, not 
only the results of these operations, but also the associated morbidities, are 
similar in older and younger populations. Therefore, it is not surprising that 
postoperative ileus (POI) affects patients of all ages. POI is a multifactorial 
condition that is exacerbated by opioid analgesics, bed rest and other conditions 
that may be rather prevalent in the postoperative elderly patient. Therefore, as 
major surgical interventions are considered in this population, appropriate 
102 
 
assessment and, ideally, correction of any physiological disturbances should be 
undertaken along with implementation of standardized enhanced recovery 
protocols. Ideally, through this combined approach, an appreciable impact can be 
made on reducing POI while controlling postoperative pain and limiting 
postoperative thromboembolic, cardiopulmonary, cerebral and infectious 
complications. This article reviews the potential impact of pharmacological 
agents, laparoscopy and other maneuvers on POI in the elderly. 
 
Introduction 
      The 20th century has been characterized by the steepest rise in the world’s 
population and the sharpest increase in human life span ever seen. Life expectancy in 
developed countries for the last 100 years has almost doubled and now ranges from 76 
to 80 years (1, 2). Every year in France, life expectancy increases by 3 months (3). It has 
been recognized that chronological age does not necessarily correlate with physiological 
aging; thus, the assignment of terms such as ‘elderly’ or ‘old’ to all patients aged > 65 
years during workup and evaluation should be more flexible and dependent on criteria 
other than chronological age. The most widely used system divides these individuals into 
the ‘young-old’ (aged 65–74 years), the ‘old-old’ (aged 75–84 years), and the ‘oldest-old’ 
(aged > 85 years) (4).  
      In 2000, those aged > 65 years comprised 35 million people (or 12%of the US 
population) (5). Within this group, 18.5 million people (53%) were young-old, 12.3 million 
(35%) were old-old and 4.2 million (12%) were oldest-old. Among these three groups, 
the oldest-old group is the fastest growing population. Further aging is predicted to 
increase the population aged > 65 years from 35 million in 2000 to 40 million in 2010 (a 
14%increase) and then to 55 million in 2020 (a 38%increase for that decade). It is 
predicted that by 2030 the population of people aged > 65 years will reach 72 million, 
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which is almost twice the number in 2007 (6). In Finland, the percentage of people aged 
> 65 years by the end of the 20th century was 12%and is projected to double by 2030 
(7). The current healthcare system would need to deal with results similar to the 
demographic phenomenon that happened after World War II, called the ‘baby boom’ 
generation. There is a cohort of 74 million people born in the years 1946–64 currently 
reaching age 45–63 years in the US alone (8).  
 
Change of Surgical Dogma Regarding Age as a Relative Contraindication to 
Surgery 
      The aging of the population has forced a significant trend towards an increase in 
hospitalizations for all groups of the elderly, with many varied and often challenging 
problems (9-14). New medical sub-specializations with geriatric research interests are 
emerging in all medical fields, such as geriatric oncology and geriatric anesthesiology (3, 
15, 16).  It is common knowledge that more than 50% of all cancers are diagnosed in the 
population of patients aged > 70 years (17). The growth in the proportion of patients with 
cancer in older age groups has been accompanied by a constant increase in the volume 
of elderly patients in surgical oncology. A recent study from Portland, Oregon, USA, 
showed that nearly one third of colon cancers in the state of Oregon are diagnosed in 
patients aged > 80 years (18). Most of these cancers are surgically managed and tumour 
eradication is required with minimal denial of surgery on the basis of patients’ age. 
Advances in anesthesia, intensive care and perioperative care unit support have 
significantly decreased the surgical threshold, which in turn allows acceptance of the 
older population not only for emergent (7, 19) but also for elective surgical procedures 
(20). 
      Despite reports of more frequent multi-morbidity in patients aged >75 years and a 
higher rate of postoperative complications (21-24), there is a general consensus that 
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advanced age is in itself not a contraindication to colorectal surgery (24-29). It is not 
chronological age but rather co-morbidities that define the outcomes of surgery (30-33). 
Several reports state that intraoperative complications are no more frequent in the older 
patient than in the younger patient (24, 34-36). A popular surgical aphorism is that ‘‘all 
postoperative complications begin in the operating room” (37). This applies equally to all 
specific postoperative complications, including ileus, transit disorders, wound healing, 
after-bleeds and anastomotic leakage (24, 34, 35). As a logical result of this, decisions 
about life-saving procedures, such as cancer surgery, and about procedures related to 
diseases with a major impact on patients’ quality of life, such as rectal prolapse, should 
not be influenced by patients’ chronological age but perhaps should be tailored to 
individual preoperative co-morbidities, particularly cardiopulmonary and respiratory 
diseases (21, 22, 24, 34, 36), which are the underlying basis for general postoperative 
morbidity. 
 
Postoperative Ileus (POI) in the Elderly 
      With the great advances in medicine in the 20th century, the risks of infection, 
anastomotic complications, bleeding and thromboembolic events have been successfully 
reduced (38-41). By contrast, neither the incidence nor the clinical impacts of 
postoperative ileus (POI) have significantly changed as yet. This can be explained by the 
characteristics of POI, which is not life-threatening and somewhat unpreventable. 
However, its negative impact in terms of prolonging length of hospital stay has been 
estimated to cost $US1.46 billion annually in the US (year of costing 2002) (42). The 
difficulty in performing pharmacoeconomic analyses of treatment for POI stems from the 
absence of a clearly identified population by administrative datasets. Confusion arises 
when patients without any precipitating complication (primary POI) are grouped with 
patients who have precipitating complications (secondary POI) (43). As described by 
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Kehlet and Holte (44), POI is a temporary impairment of gastrointestinal tract function 
and motility, mostly found after abdominal surgery. This delay in the coordinated 
movements of the gastrointestinal tract is different to the inevitable response to surgical 
trauma, from which patients typically recover within 3–5 days after surgery (45). It is 
comprised of a combination of various signs such as abdominal distension, lack of bowel 
sounds, accumulation of gas and fluids in the bowel lumen and delayed passage of 
flatus and stool. The symptoms range from cramping and abdominal pain to nausea and 
vomiting. 
      POI has multifactorial etiologies and its pathophysiology is not yet completely 
understood. Correlation with the degree of surgical trauma, the site of surgical 
intervention, the patient’s preoperative medical condition, the length of the operation, the 
stimulation of gut opioid receptors by endogenous and exogenous opioid analgesics, the 
presence of surgical infection and many other factors has been reported in animal 
models (46). Modern views on POI pathogenesis are based on studies that show that 
activation of the sympathetic nervous system (SNS) by surgical stress plays a significant 
role (45).  Also significant is the release of inflammatory mediators and the immigration 
of leucocytes into the intestinal wall, both of which contribute to the paralysis of intestinal 
smooth muscle tissue (46, 47). Moreover, excess perioperative intravenous fluid can 
impair bowel motility as a consequence of edema of the intestinal wall (48). 
      Aging alone is associated with gradual loss of reserve capacity, even in the individual 
without co-morbidities (49). This also reduces the older patient’s ability to tolerate stress 
(49). While the pathogenesis of POI is still unknown, there should be no difference in its 
pathogenesis between elderly and younger patients, regardless of  reoperative co-
morbidities. The level of stress arising from surgical trauma plays an important role in 
increasing or decreasing the incidence of POI. Hong et al. (50) and Asgeirsson et al. (51) 
demonstrated that laparoscopy reduces the risk of POI compared with laparotomy but 
does not eliminate the risk. Table I shows a trend for higher incidence of POI in elderly 
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patients. However, most reports are limited by the accuracy of clinical documentation, 
inconsistency of billing and coding, and definitional differences among clinicians (51). 
The elderly population in general is characterized by changes in several physiological 
parameters that may be responsible for a higher incidence of POI. With respect to renal 
function, it is known that older patients tend to have decreased filtration area of the 
glomerular basement membrane with a concomitant decrease in glomerular filtration rate 
of about 40–50%; decreased permeability of the basement membrane; decreased 
tubular function; and decreased urine concentration (17). Liver function is also affected, 
with a decrease in hepatic blood flow and decreased serum albumin concentration and 
cytochrome P450 enzyme function. In terms of cardiovascular function, there is a greater 
incidence of occlusive disease of coronary, carotid and vertebral arteries; a higher risk of 
myocardial infarction or stroke; more frequent peripheral vascular disease; a greater 
likelihood of abdominal or visceral aneurysm; and an increased prevalence of 
hypertension that requires more medical management. Pulmonary function in the elderly 
is characterized by less pulmonary reserve and a higher incidence of chronic obstructive 
pulmonary disease or lung malignancies. The elderly population also has a higher 
prevalence of risk factors and other comorbidities, such as past or current diabetes 
mellitus, tobacco use, alcoholism, malignancies, arthritis and orthopedic procedures. 
Finally, there is a greater risk of under-nutrition or malnutrition in this age group (17). 
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Table 1 Postoperative ileus (POI) following colorectal surgery 
Study                                              n               Surgery type               Younger patients       Elderly patients 
                                                                                                            age (y)     POI (%)      age (y)      POI (%) 
Scheidbach et al. (52) 2005.        49                     lap                         <75            0.8             >75             1.8 
Chautard et al. (53), 2008.           178                   lap                         <70             4.9            >70             9.3 
Person et al. (54]), 2008.              291                 open                        <65            7.9            >65              7.8 
                                                      264                   lap                         <65            3.8            >65              3.7 
                                                       86                   conv                       <65             6.6            >65            16.0 
Louis et al. (20), 2009.                  157              lap+open                     NA             NA            >80              8.9 
Lian et al. (55), 2010.                     97                  open                         NA             NA            >80            19.6 
                                                       97                     lap                         NA              NA           >80             17.5 
Note: conv=conversion (from laparoscopic to open surgery);lap=laparoscopy; NA=not applicable 
 
      Although there have been improvements in perioperative care during the last 3 
decades, these have not dramatically affected the prognosis of elderly patients who 
require emergency surgery (56). Elective surgery, together with careful preoperative 
evaluation and correction, is preferred to limit the impact of naturally decreased 
functional reserve in each organ system after surgery. There is no universally accepted 
tool for the measurement of medical co-morbidities among elderly patients; scales vary 
between individual surgeons, groups and institutions (57). The most commonly used 
method is probably the American Society of Anesthesiologists (ASA) system of 
classifying preoperative risk. A recent report from Illinois, USA, also confirmed that 
emergency status and ASA class are useful predictors of perioperative morbidity, 
including POI (20).  
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Fast-Track and Enhanced Recovery Protocol 
      POI treatment has historically been of a mostly supportive, retroactive nature. The 
idea of a ‘stress- and pain-free operation’ was first introduced as the ‘fast-track protocol’ 
in the mid-1990s by Kehlet and Wilmore (58). The fast track protocol includes 
recommendations for preoperative, perioperative and postoperative care. 
Recommendations for preoperative care include counselling, feeding, administration of 
antibacterial, no bowel preparation, no pre-medication and fluid restriction (59). The 
recommended perioperative measures are high O2 concentrations, active prevention of 
hypothermia, epidural analgesia and minimally invasive surgery/transverse incisions. 
Recommendations for postoperative care include selective use of nasogastric (NG) 
tubes, avoidance of drains, enforced mobilization, enforced early oral feeding, avoidance 
of systemic use of opioids, use of standard laxatives and early removal of urinary 
catheters (59). 
      Gastrointestinal tract motility is controlled by three nervous systems (60): the 
parasympathetic nervous system (PNS) and the SNS (which together make up the 
extrinsic nervous system), and the intrinsic nervous system (45, 61). The PNS acts to 
increase intestinal motility, whereas activation of the SNS inhibits bowel function. POI is 
believed to be related to the longevity of a high sympathetic state activated by surgical 
stress (45, 62). Because the contraction and motility of the colonic cells are more 
dependent on the extrinsic nervous system (PNS and SNS), unlike the cells of the small 
intestine, a longer duration of high sympathetic outflow would prolong the duration of 
POI. In addition, the colon relies on the presence of material in the lumen to stimulate its 
function in the absence of the migrating motor complex, which is located specifically in 
the stomach and small bowel (45, 63). Routine preoperative fasting may further prolong 
recovery of the colon. Better understanding of the pathophysiological events occurring 
during and after surgery has made the fast-track protocol possible. 
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      Early application of these principles showed a decrease in hospital stay after open 
colectomy in a group of patients (median age 71 years) to a median of 2 (range 2–6) 
days (64). Polle et al. (65) demonstrated that implementing a mean 7.4 of the 13 
previously listed fast-track modalities resulted in a significant reduction in length of 
primary hospital stay in the fast-track group compared with the traditional-care group (4.5 
vs 8 days, p=0.02) without any increase in morbidity. Gouvas et al. (59), in a meta-
analysis published in 2009, evaluated 11 studies involving 1021 patients who were 
divided into a fast-track group (526 patients) and a standard-care group (495 patients). 
Results showed significantly shorter primary and total hospital stays and lower 
immediate postoperative morbidity rates for the fast-track group in comparison with the 
standard-care group (all p<0.00001). The analysis found no differences in readmission 
rates or mortality rates between the two groups. The investigators concluded that there is 
good evidence that fast-track programs should form the mainstay of patient care for 
elective colorectal surgery. Successful implementation of fast-track programs requires a 
joint effort by a committed well trained and experienced multidisciplinary team of 
anesthesiologists, surgeons, dieticians, physiotherapists, pharmacologists and 
appropriately trained and dedicated nurses, coupled with the understanding and 
compliance of the patient and his or her family as well (59). Characteristic bottlenecks 
may be encountered initially as surgical dogmas need to be debunked and new ideas, 
such as early rather than delayed mobilization, preoperative feeding instead of 
preoperative fasting, avoidance of NG tubes and drains, fluid restriction, and the 
introduction of laparoscopic surgery, are adopted (65).  
      Disbrow et al. (66) reported an interesting result of preoperative psychological 
suggestion that may impact postoperative outcome. These investigators demonstrated 
that patients given preoperative information on the early return of gastrointestinal activity 
had a significant decrease in the length of POI (2.6 vs 4.1 days) and earlier time to 
hospital discharge (6.5 vs 8.1 days), compared with patients not given this information.  
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      Traditional use of NG tubes has been challenged in the past, with several reports 
failing to show the advantage of routine NG tube insertion (67, 68). Use of an NG tube 
did not shorten the time to first bowel movement or effective oral intake; furthermore, 
routine use of an NG tube was associated with more episodes of fever, atelectasis and 
pneumonia as well as slower return to oral intake. Although patients who were not 
treated with an NG tube had an increased incidence of abdominal bloating and vomiting, 
no overall increase in postoperative complications was seen. Similarly, the traditional 
belief that early ambulation may stimulate gastrointestinal tract motility has not been 
proven in studies. Conversely, early ambulation has indisputably been shown to help 
prevent atelectasis, pneumonia and deep venous thrombosis (69).  
      Restrictive fluid administration aimed at maintaining normovolemia provides 
adequate organ perfusion, whereas overloaded fluid administration may adversely affect 
perioperative organ function, e.g. by causing intestinal edema that might prolong the 
duration of POI (especially if the fluid excess involves a large volume of saline) and delay 
recovery (70-72). A fast-track protocol has implications for perioperative fluid 
management because patients are allowed to eat and drink freely immediately after the 
operation, thus minimizing use of postoperative intravenous fluid administration. A recent 
randomized, controlled, double-blind trial conducted in Denmark found that the restrictive 
fluid regimen of fast-track surgery led to improvements in pulmonary function and 
postoperative hypoxaemia, whereas no differences in POI, exercise capacity or other 
recovery measures were found (73). 
      Minimally invasive surgery and laparoscopy play significant roles in decreasing the 
incidence, length and severity of POI. It is thought that laparoscopic surgery is 
associated with decreased surgical trauma with better preservation of immune function, 
decreased inflammatory responses and decreased pain and catabolism compared with 
open surgery (58, 73-75).  These benefits are manifested by a decreased incidence of 
POI, faster recovery and increased patient satisfaction. The 2005 Cochrane review of the 
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short-term benefits of laparoscopic colorectal resection concluded that the intensity of 
postoperative pain (evaluated by a visual analogue scale) was lower and that the mean 
duration of POI was 0.9 days shorter after laparoscopic colorectal resection than after 
open surgery (76).  These authors also found that postoperative pulmonary function 
(forced vital capacity) improved more rapidly after a laparoscopic approach. 
      Laparoscopy has also proven its benefits in high-risk patients, defined by Marks et al. 
(77) as being aged >80 years, morbidly obese (body mass index >30 kg/m2), having an 
elevated ASA class of 3 or 4, or having a history of previous radiation. Their experience 
of 190 high-risk patients (median age 66 years) showed that laparoscopic colorectal 
resection, in the hand of experienced surgeons, could be performed safely and result in 
decreased morbidity and shorter hospital stay than open surgery. These investigators 
suggested that increased age, morbid obesity, high ASA class or preoperative radiation 
should not be contraindications to laparoscopic colorectal surgery. Data from a 
prospective, observational, multicentre study of patients aged <75 or >75 years 
undergoing open or laparoscopic colectomy in 105 hospitals in Germany, Austria, 
Switzerland and Italy showed a highly statistically significant difference between the two 
age groups for virtually all of the individual complications and mortality with no significant 
difference in complications directly associated with the procedure necessitating re-
operation (bleeding, anastomotic leak, POI) (52). The investigators noted that the use of 
age as a consideration for laparoscopic surgery should be individualized. They also 
concluded that the surgeon should consider preferential use of laparoscopy in colorectal 
surgery because of the advantages of the laparoscopic approach with regard to the 
postoperative course. 
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Fast-Track Protocol in Geriatric Patients 
      In addition to the ordinary fast-track protocol, a modified geriatric fast-track program 
is a reasonable option for the provision of elderly-oriented surgical care. Such a program 
needs to include additional points of care in relation to postoperative delirium, which can 
be present in up to 53%of elderly post-surgical patients (78). On this point, it is 
interesting to note that between 32% and 96% of patients with new onset symptoms of 
delirium leave the hospital without resolution of these symptoms, which may take weeks 
or months to resolve (78).  The traditional fast-track philosophy of providing a quick 
guided tour around the hospital has particular benefit in the geriatric-modified protocol. A 
preoperative tour of the medical facility to familiarize the older patient with his or her 
future ward, floor and building might be potentially helpful in decreasing the incidence 
and severity of postoperative delirium. Gurlit and Mollmann (79) listed the following 
environmental risks that contribute to the development of delirium in elderly surgical 
patients: confusion associated with an overnight stay in a new place; noisy situations; 
absence of reading glasses, hearing aids and clocks/watches; introduction of new 
medications; use of psychoactive drugs to induce sleep at night; scheduling of diagnostic 
interventions at mealtimes; and sleep deprivation (79).  
      Demeure and Fain (78) have suggested several valuable recommendations for 
decreasing delirium manifestations in the elderly population after surgery. These include 
early return of hearing aids and eyeglasses as soon as patients are able to use them; 
provision of large-dial clocks, menus and newspapers with large print; allowing a family 
member to stay with the patient or having the patient bring familiar articles, such as 
framed photographs, from the home into the hospital room; facilitating access to radio 
and other audio/ video modalities that the patient is comfortable with; providing room 
lighting that matches the normal daily rhythm of waking and sleeping hours; and 
minimization, as much as possible, of night-time disturbances of sleep, such as hall 
noises and the waking of patients to measure routine vital signs (78).  
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      A combination of all these measures should decrease the level of postoperative 
cognitive dysfunction, which is described as a cognitive impairment of executive 
functions (concentration/processing speed/self-monitoring), learning, memory, 
visuospatial abstraction, language comprehension and verbal memory (80-82).  The 
available evidence shows that older adults have longerlasting cognitive impairment after 
major surgeries and that postsurgical cognitive impairment may herald greater mortality 
(80-82). 
      Co-management of older surgical patients by surgeons and other doctors 
specializing in hospital medicine (hospitalists) is one way of establishing the initial fast-
track team (83). Providing a designated geriatric nurse who can become a ‘constant 
companion’, a well-known face amongst all the patient’s hospital relationships, is a very 
helpful measure in optimizing surgical care (79). Kehlet and Wilmore (84) described an 
algorithm for the initiation and implementation of an enhanced postoperative recovery 
program that starts with a simple interest in the program. The algorithm consists of 
several steps and emphasizes the importance of team meetings, writing and discussing 
protocols and developing care plans. 
 
Pharmacological Treatment of POI 
      Successful pharmacological treatment of POI has been a long-awaited dream for 
surgeons. The desire for a single ‘magic pill’ that would eliminate the frustration of ileus 
in postoperative recovery resulted in the trial of various pharmacological agents (85).  
However, since POI is multifactorial, it is somewhat unrealistic to expect total elimination 
of the condition with one medication. Nevertheless, the combination of a fast-track 
protocol with a dedicated team and a clinical pharmacologist may result in some benefit.  
      The Cochrane systematic review published in 2008 analyzed data from 39 
randomized, controlled trials involving 4615 patients who underwent major abdominal 
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surgery, major abdominal-vascular surgery or major abdominal urological and 
gynecological surgery (48).  The main endpoint of the review was to evaluate the effects 
of systemic prokinetic pharmacological treatments for POI. The authors evaluated the 
following medications that were commonly used to treat POI: cholinergic receptor 
agonists (bethanechol chloride, neostigmine), benzamides (cisapride, metoclopramide, 
bromopride), dopamine receptor antagonists (domperidone), peptide hormones 
(cholecystokinin, ceruletide, vasopressin), Beta-adrenoceptor antagonists (propranolol), 
macrolide antibacterial (erythromycin), ergotamine derivates (dihydroergotamine 
mesilate), systemic administration of local anesthetics, prostaglandins, vitamins (calcium 
pantothenate [pantothenic acid], dexpanthenol) and selective gastrointestinal opioid 
receptor antagonists. However, with the exception of two u-opioid receptor antagonists, 
none of these medications are US FDA approved for the treatment of POI. In addition, in 
2000, cisapride was withdrawn from the medical market in many countries, including the 
US, because of serious cardiac events. 
      The review found that the prokinetic activities of erythromycin, cholecystokinin, 
cisapride, dopamine receptor antagonists, propranolol and vasopressin are not effective 
in the treatment of POI (48). Although intravenous lidocaine (lignocaine) and neostigmine 
might be beneficial, further well designed studies are required to provide proof.  
      Opioids are widely used in postoperative pain management. Their pain control 
mechanism is realized though Mu-opioid receptors in the CNS. The same Mu-opioid 
receptors are also present in the gastrointestinal tract and activation of these peripherally 
located receptors impairs bowel motility. Peripheral selective gastrointestinal opioid 
receptor antagonists that can block these receptors without reversing the central 
analgesic effects of Mu-opioid receptor agonists would be a desirable mechanism of 
POI-reducing medications. 
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      A more specific Cochrane systematic review of Mu-opioid receptor antagonists for 
opioid-induced bowel dysfunction included 23 studies involving 2,871 patients (86). The 
authors reviewed the effects of alvimopan (nine studies), methylnaltrexone bromide (six 
studies), naloxone (seven studies) and nalbuphine (one study). Meta-analysis of these 
anti-POI medications included combined endpoints such as time to flatus/bowel 
movement, time to flatus/bowel movement/solid food and time to solid food/bowel 
movement. The results showed that methylnaltrexone bromide and alvimopan were both 
superior to placebo at reversing opioid-induced increased gastrointestinal transit time 
and constipation, and that alvimopan appears to be safe and efficacious in treating POI. 
The review also found that the incidence of adverse events with opioid receptor 
antagonists was similar to that with placebo and that these events were generally 
reported as mild or moderate. The authors concluded that although alvimopan and 
methylnaltrexone bromide have shown promise in the treatment of constipation as well 
as POI, further data are required to fully assess the place of these medications in 
therapy. 
Alvimopan 
      Alvimopan is the first FDA-approved drug (in May 2008) that has been proven to 
accelerate the time to upper and lower gastrointestinal recovery following partial large or 
small bowel resection surgery with primary anastomosis in the US (87). Alvimopan 
antagonizes the peripheral effects of opioids on gastrointestinal motility and secretion by 
competitively binding to gastrointestinal tract Mu-opioid receptors (88). In clinical trials, 
alvimopan did not reverse opioid analgesia, as measured by visual analogue scale pain 
intensity scores and/or the amount of postoperative opioids administered. Alvimopan is 
an antagonist of cloned human Mu-opioid receptors (Ki [inhibition constant] 0.4 nmol/L 
[0.2 ng/mL]) with a median time to reach maximum plasma concentration of 2 hours, a 
bioavailability of ~6%, 65% biliary and 35% renal excretion, a mean terminal half-life of 
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10–17 hours and no measurable opioid-receptor agonist effects in standard 
pharmacological assays (88).  
      Alvimopan is currently approved only for short-term use in hospitalized patients. Only 
hospitals that have registered with the manufacturer and have met all of the 
requirements for the EnteregR Access Support and Education (EASETM) program may 
use alvimopan at this time. The recommended adult dosage of alvimopan is 12 mg 
administered 30 minutes to 5 hours prior to surgery followed by 12 mg twice daily 
beginning the day after surgery for a maximum of 7 days or until discharge (88). Patients 
should not receive more than 15 doses during their hospital stay. Alvimopan is 
contraindicated in patients who have taken therapeutic doses of opioids for more than 7 
consecutive days immediately prior to taking alvimopan (89). Alvimopan is not 
recommended for use in patients with severe hepatic impairment or end-stage renal 
disease, or in patients undergoing surgery for correction of complete bowel obstruction.  
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Table 2 Laboratory tests for healthy patients undergoing major 
surgery at Cleveland Clinic Florida 
          Age (y)                                                                Laboratory test 
                                                                             Men                          Women 
           <40                                                             Hct or Hgb                   Hct or Hgb 
                                                                                    T&S                            T&S 
         40–49                                                            Hct or Hgb                   Hct or Hgb 
                                                                                    T&S                            T&S 
                                                                                    ECG 
          50–64                                                           Hct or Hgb                   Hct or Hgb 
                                                                                    T&S                             T&S 
                                                                                    ECG                            ECG 
          65–74                                                           Hct or Hgb                    Hct or Hgb 
                                                                                     T&S                             T&S 
                                                                                     ECG                            ECG 
                                                                                BUN or Cr                    BUN or Cr 
             >75                                                             Hct or Hgb                    Hct or Hgb 
                                                                                      T&S                             T&S 
                                                                                      ECG                                   ECG 
                                                                                 BUN or Cr                    BUN or Cr 
                                                                                    Glucose                        Glucose 
                                                                                      CXR                             CXR 
BUN=blood urea nitrogen; Cr=creatinine; CXR=chest x-ray; Hct=hematocrit; Hgb=hemoglobin; T&S=type 
and screen. 
 
 
Methylnaltrexone Bromide 
      Currently, methylnaltrexone bromide is approved by the FDA as a subcutaneous 
formulation for the treatment of opioid-induced bowel dysfunction (constipation) as part 
of palliative care for patients with advanced illnesses such as incurable cancer, AIDS or 
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end-stage heart or lung disease, for methadone users, and for patients with chronic pain 
(88). Use of methylnaltrexone bromide has never been specifically assessed in the 
geriatric population. 
 
Gum Chewing 
      Vagal cholinergic tone in the gastrointestinal tract can be simply and effectively 
stimulated by gum chewing (90, 91). This type of sham feeding also elicits the release of 
gastrin, pancreatic polypeptide and neurotensin, all of which affect gastrointestinal 
motility (90, 91).  A systematic review and meta-analysis that evaluated 437 patients 
from nine eligible trials demonstrated that chewing sugarless gum following elective 
intestinal resection is associated with improved outcomes (a lower incidence of POI) 
(92). Asao et al. (93) conducted a randomized, prospective study of gum chewing as a 
method to stimulate bowel motility after laparoscopic colectomy for colorectal cancer. 
These investigators found that the passage of first flatus was a mean 1.1 days earlier in 
the gum-chewing group than in the control group (occurring on day 2.1 vs 3.2, 
respectively). The time to first defecation was also significantly earlier in the gum-
chewing patients than in controls (on postoperative day 3 vs 5.8, respectively). However, 
the mean length of hospital stay was not significantly different between the two groups 
(13.5 vs 14.5 days, respectively) (93).  
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) 
      Nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended by enhanced 
recovery protocols after elective colorectal surgery (94). The opioid-sparing and anti-
inflammatory properties of NSAIDs are attractive in the postoperative setting. NSAIDs 
can be considered as alternative analgesia to avoid undesirable effects of opioid, such 
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as constipation, sedation, and respiratory depression. Their anti-inflammatory properties 
may also be valuable for accelerating the recovery of bowel function by inhibiting the 
synthesis of prostaglandins and reducing neuromuscular dysfunction (95). On the other 
hand, the use of NSAIDs after colorectal surgery is controversial. Their nephrotoxic 
properties increase the risk of acute kidney injury, which is associated with increased 1-
year mortality after noncardiac surgery (96). They may also be associated with an 
increased risk of anastomotic leak according to some observational studies (97, 98). 
      NSAIDs exert their anti-inflammatory effects through inhibition of COX-1 and COX-2, 
subsequently leading to inhibition of prostaglandins. This is relevant in the days after 
surgery, where the effects of ileus are probably mediated by a cascade of mast cells, 
macrophages, and inflammatory cytokines involving the bowel muscularis (95).Previous 
research has shown that this inflammatory response is safely mitigated using 
pharmacological and nonpharmacological interventions, and, in doing so, the return of GI 
function can be accelerated (99). On this notion, NSAIDs may represent a cost-effective 
and accessible intervention to improve GI recovery while also providing effective 
postoperative analgesia. 
 
TZP-101 
      TZP-101 is a selective, small molecule ghrelin agonist in clinical development as a 
treatment for gastric dysmotility disorders. Ghrelin is the natural ligand for growth 
hormone secretagogue receptors (GHSR-1a), and both ghrelin and GHSR-1a are 
colocalized in the proximal gastrointestinal tract (100). The ghrelin receptor pathway 
mediates multiple gastrointestinal functions, including motility, gastric emptying, and 
induction of migrating motor complexes (MMCs) (101). Compared with ghrelin, TZP-101 
has enhanced metabolic stability and high affinity (Ki22 nM) for the human type 1a 
GHSR, (102) and shows prokinetic activity in animal models of POI (103, 104) and in 
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patients with gastroparesis (105). While all TZP-101 doses decreased the time to 
recovery of first bowel movement (or time to first toleration of solid food), the most 
notable effects were consistently in the 480g/kg dose group. These results were 
supported by the secondary gastrointestinal recovery end points such as time to first 
flatus, time to toleration of solid food, and time to eligibility for discharge, which were all 
statistically significant at that dose. For these reasons, 480g/kg was identified as the 
most effective dose (106).  
 
Patient Evaluation and Enhanced Recovery Protocol at Cleveland Clinic Florida 
      Healthy surgical patients treated at Cleveland Clinic Florida (Weston, FL, USA) 
undergo individualized preoperative evaluations depending on their chronological age 
and co-morbidities (table II). The adjusted enhanced recovery protocol used at Cleveland 
Clinic Florida is shown in table III.  
Conclusions 
      As the population of developed countries ages, a wider acceptance of people aged 
>65 years for surgical procedures has become routine. Studies show that chronological 
age is no longer a limiting factor for surgical treatment. This shift of surgical dogma has 
potentially led to the increase in the incidence of POI associated with major surgery. POI 
is a multifactorial condition, requiring prophylaxis at every step in the preoperative, 
perioperative and postoperative periods. Assessment and correction of physiological 
disturbances in older patients with implementation of enhanced recovery protocols may 
lead to significant reductions in POI and pain levels, as well as decreases in 
cardiopulmonary, thromboembolic, infectious and cerebral/cognitive complications. 
Laparoscopy has shown significant benefits in this elderly population. In addition, there 
are new pharmacological agents with proven effects in relation to shortening the duration 
of POI, although not specifically in the geriatric population. 
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Table 3: Enhanced recovery protocol for patients undergoing 
colorectal surgery at Cleveland Clinic Florida 
Operative period     Visit/perioperative day   Activity 
Preoperative           Initial office visit             -Discussion of aspects of surgery, potential risks, complications 
                                                                       and alternatives. Description of the range of required 
                                                                       preoperative tests (internal medicine or cardiology clearance,  
                                                                       blood work, etc.) 
                                                                      -Giving out handouts to patients defining expectations of  
                                                                       early ambulation, return of bowel function, projected discharge 
                                                                       criteria. 
                                                                              -Giving out handouts to patients listing medications to avoid  
                                                                               prior to surgery to prevent intra- or postoperative bleeding. 
                                                                              -If a stoma is considered a possibility, education by dedicated  
                                                                               stoma nurses regarding care andmanagement;  
                                                                               preoperative marking. 
Perioperative                   0                           -Subcutaneous heparin (5000 units); pneumatic stockings. 
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                                                                     -May receive spinal anesthesia. 
                                                                     -Oro/nasogastric tube removed at extubation. 
Postoperative                   1                          -Enforced early postoperative mobilization (5 laps in the  
                                                                      hallway, approximately 100 m). 
                                                                     -Clear liquid diet, ice chips 
                                                                            -Subcutaneous heparin (5000 units every 8 hours during 
                                                                              hospital stay); pneumatic stockings. 
                                                                            -Incentive spirometry exercises (to prevent respiratory problems). 
                                           2                        -Awaiting flatus or bowel movement. 
                                                                     -Removal of dressing. 
                                                                     -Removal of bladder catheter. 
                                            3                       -If flatus or bowel movement present, advance to full liquid diet. 
                                                                     -Hep-Lock intravenous fluids. 
                                                                     -Discontinue patient-controlled analgesia pump. 
                                                                     -Oral pain medication. 
                                            4                       -Advance to low-residue diet unless distended. 
                                                                            -Anticipate discharge home 
References 
1. Centers for Disease Control and Prevention. Public health and aging: trends in aging–
United States and worldwide. JAMA. 2003 Mar 19; 289 (11): 1371-3. 
2. Diczfalusy E. An aging humankind: new realities. Women’s Health Menopause. 1999; 13: 
1-4. 
3. Misset JL, Bauer C. What is an ‘‘elderly’’ oncologic patient? Crit Rev Oncol Hemat. 2008 
July; 67(1): 62-3. 
4. Yancik R, Ries LG. Cancer in the aged: an epidemiologic perspective on treatment issues. 
Cancer. 1991 Dec 1; 68 (Suppl.11): 2502-10. 
5. Gist YJ, Hetzel LI. We the people: aging in the United States. Washington, DC: US 
Census Bureau, 2004. 
123 
 
6. Future growth. In: A profile of older Americans 2008. Washington, DC: US Department of 
Health and Human Services, Administration on Aging, 2008. 
7. Miettinen P, Pasanen P, Salonen A, et al. The outcome of elderly patients after operation 
for acute abdomen. Ann Chir Gynaecol. 1996;85(1): 11-5. 
8. Martini EM, Garrett N, Lindquist T, et al. The boomers are coming: a total cost of care 
model of the impact of population aging on health care costs in the United States by Major 
Practice Category. Health Serv Res. 2007 Feb; 42 (1 Pt 1): 201-18. 
9. Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly 
Medicare patients for pneumonia, 1991-1998. Am J Public Health. 2001 Jul;91(7): 1121-3. 
10. Baine WB, Yu W, Summe JP. The epidemiology of hospitalization of elderly Americans 
for septicemia or bacteremia in 1991-1998: application of Medicare claims data. Ann 
Epidemiol. 2001 Feb;11(2): 118-26. 
11. Baine WB, Yu W, Weis KA. Trends and outcomes in the hospitalization of older 
Americans for cardiac conduction disorders or arrhythmias, 1991-1998. J Am Geriatr Soc. 
2001 Jun;49(6): 763-7. 
12. Curns AT, Steiner CA, Sejvar JJ, et al. Hospital charges attributable to a primary 
diagnosis of infectious diseases in older adults in the United States, 1998 to 2004. J Am 
Geriatr Soc. 2008 Jun;56(6):969-75. doi: 10.1111/j.1532-5415.2008.01712.x. Epub 2008 Apr 
10. 
13. Hebert PL, McBean AM, Kane RL. Explaining trends in hospitalizations for pneumonia 
and influenza in the elderly. Med Care Res Rev. 2005 Oct;62(5): 560-82. 
14. Russo CA, Elixhauser A. Statistical brief #6: hospitalizations in the elderly population, 
2003. Rockville (MD): Agency for Healthcare Research and Quality, 2006. 
15. Muravchick S. Syllabus on geriatric anesthesiology. Gerontology. 2006; 23: 3-78. 
124 
 
16. Moore JL, Birren JE. Doctoral training in gerontology: an analysis of dissertations on 
problems of aging in institutions of higher learning in the United States, 1934-1969. J 
Gerontol. 1971 Apr;26(2): 249-57. 
17. Pasetto LM, Lise M, Monfardini S. Preoperative assessment of elderly cancer patients. 
Crit Rev Oncol Hematol. 2007 Oct;64(1): 10-8. 
18. Hardiman KM, Cone M, Sheppard BC, et al. Disparities in the treatment of colon cancer 
in octogenarians. Am J Surg. 2009 May;197(5):624-8. doi: 10.1016/j.amjsurg.2008.12.018. 
19. Chiappini B, Tan ME, Morshuis W, et al. Surgery for acute type A aortic dissection: is 
advanced age a contraindication? Ann Thorac Surg. 2004 Aug;78(2):585-90. 
20. Louis DJ, Hsu A, Brand MI, et al. Morbidity and mortality in octogenarians and older 
undergoing major intestinal surgery. Dis Colon Rectum. 2009 Jan;52(1):59-63. doi: 
10.1007/DCR.0b013e31819754d4. 
21. Adloff M, Ollier JC, Schloegel M, et al. Colorectal cancer in patients over the age of 80 
years. Ann Chir. 1993;47(6): 492-6. 
22. Arnaud JP, Schloegel M, Ollier JC, et al. Colorectal cancer in patients over 80 years of 
age. Dis Colon Rectum. 1991 Oct;34(10): 896-8. 
23. Avital S, Kashtan H, Hadad R, et al. Survival of colorectal carcinoma in the elderly: a 
prospective study of colorectal carcinoma and a five-year follow-up. Dis Colon Rectum. 1997 
May;40(5): 523-9. 
24. Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: 
a systematic review. Lancet. 2000 Sep 16;356(9234):968-74. 
25. Damhuis RA, Wereldsma JC, Wiggers T. The influence of age on resection rates and 
postoperative mortality in 6457 patients with colorectal cancer. Int J Colorectal Dis. 
1996;11(1): 45-8. 
125 
 
26. Edna TH, Bjerkeset T. Colorectal cancer in patients over 80 years of age. 
Hepatogastroenterology. 1998 Jan;45(1): 42-5. 
27. Fabre JM, Rouanet P, Ele N, et al. Colorectal carcinoma in patients aged 75 years and 
more: factors influencing short and long-term operative mortality. Int Surg. 1993 Jul-Sep; 78 
(3): 200-3. 
28. Hessman O, Bergkvist L, Strom S. Colorectal cancer in patients over 75 years of age: 
determinants of outcome. Eur J Surg Oncol. 1997 Feb;23(1): 13-9. 
29. Kemeny MM, Busch-Devereaux E, Merriam LT, et al. Cancer surgery in the elderly. 
Hematol Oncol Clin North Am. 2000 Feb;14(1): 169-92. 
30. Mochiki E, Ohno T, Kamiyama Y, et al. Laparoscopy-assisted gastrectomy for early 
gastric cancer in young and elderly patients. World J Surg. 2005 Dec;29(12):1585-91. 
31. Ben-Ami I, Vaknin Z, Schneider D, et al. Peri-operative morbidity and mortality of 
gynecological oncologic surgery in elderly women. Int J Gynecol Cancer. 2006 Jan-
Feb;16(1):452-7. 
32. Kim HO, Yun JW, Shin JH, et al. Outcome of laparoscopic cholecystectomy is not 
influenced by chronological age in the elderly. World J Gastroenterol. 2009 Feb 14; 15 (6): 
722-6. 
33. McNicol L, Story DA, Leslie K, et al. Postoperative complications and mortality in older 
patients having noncardiac surgery at three Melbourne teaching hospitals. Med J Aust. 2007 
May;186(9): 447-52. 
34. Payne JE, Chapuis PH, Pheils MT. Surgery for large bowel cancer in people aged 75 
years and older. Dis Colon Rectum. 1986 Nov;29(11): 733-7. 
126 
 
35. Poon RT, Law WL, Chu KW, et al. Emergency resection and primary anastomosis for 
left-sided obstructing colorectal carcinoma in the elderly. Br J Surg. 1998 Nov;85(11): 1539-
42. 
36. Schwandner O, Schiedeck TH, Bruch HP. Advanced age: indication or contraindication 
for laparoscopic colorectal surgery? Dis Colon Rectum. 1999 Mar;42(3): 356-62. 
37. Merrell SW, McGreevy JM. Surgical aphorisms. West J Med. 1991 Jan;154(1): 110-1.   
38. Byrnes MC, Beilman GJ. Adjunctive measures for treating surgical infections and sepsis. 
Surg Clin North Am. 2009 Apr;89(2):349-63, viii. doi: 10.1016/j.suc.2008.09.001. 
39. Matthaiou DK, Peppas G, Falagas ME. Meta-analysis on surgical infections. Infect Dis 
Clin North Am. 2009 Jun;23(2):405-30. doi: 10.1016/j.idc.2009.01.012. 
40. Nichols RL. Preventing surgical site infections: a surgeon’s perspective. Emerg Infect 
Dis. 2001 Mar-Apr;7(2):220-4. 
41. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on peri-
operative cardiovascular evaluation for non-cardiac surgery: focused update on 
perioperative beta-blocker therapy: a report of the American College of Cardiology/American 
Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 
Guidelines on Peri-operative Cardiovascular Evaluation for Non-cardiac Surgery): developed 
in collaboration with the American Society of Echocardiography, American Society of 
Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, 
Society for Cardiovascular Angiography and Interventions, and Society for Vascular 
Medicine and Biology. Circulation. 2006 Jun 6;113(22): 2662-74. 
42. Goldstein JL, Matuszewski KA, Delaney CP, et al. Inpatient economic burden of 
postoperative ileus associated with abdominal surgery in the United States. P & T 2007; 32 
(2): 82-90. 
127 
 
43. Postoperative Ileus Management Council. Postoperative ileus: profiles, risk factors, and 
definitions –a framework for optimizing surgical outcomes in patients undergoing major 
abdominal and colorectal surgery [online]. Available from URL: 
http://www.ClinicalWebcasts.com/PIMC.htm [Accessed 2009 Oct 2]. 
44. Kehlet H, Holte K. Review of postoperative ileus. Am J Surg. 2001 Nov;182(5A 
Suppl):3S-10S. 
45. Livingston EH, Passaro EP. Postoperative ileus. Dig Dis Sci. 1990 Jan;35(1): 121-32. 
46. Huge A, Kreis ME, Jehle EC, et al. A model to investigate postoperative ileus with strain 
gauge transducers in awake rats. J Surg Res. 1998 Feb 1;74(2): 112-8. 
47. Neudecker J, Schwenk W, Junghans T, et al. Randomized controlled trial to examine the 
influence of thoracic epidural analgesia on postoperative ileus after laparoscopic sigmoid 
resection. Br J Surg. 1999 Oct;86(10): 1292-5. 
48. Traut U, Brugger L, Kunz R, et al. Systemic prokinetic pharmacologic treatment for 
postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database 
Syst Rev. 2008 Jan 23;(1):CD004930. doi: 10.1002/14651858.CD004930.pub3. 
49. Seymour DG, Pringle R. Post-operative complications in the elderly surgical patient. 
Gerontology. 1983;29(4): 262-70.  
50. Hong X, Mistraletti G, Zandi S. Laparoscopy for colectomy accelerates restoration of 
bowel function when using patient controlled analgesia. Can J Anaesth. 2006 Jun;53(6):544-
50. 
51. Asgeirsson T, El-Badawi KI, Mahmood A, et al. Postoperative ileus: it costs more than 
you expect. J Am Coll Surg. 2010 Feb;210(2):228-31. doi: 
10.1016/j.jamcollsurg.2009.09.028. Epub 2009 Nov 18. 
128 
 
52. Scheidbach H, Schneider C, Hugel O, et al. Laparoscopic surgery in the old patient: do 
indications and outcomes differ? Langenbecks Arch Surg. 2005 Aug;390(4):328-32. Epub 
2005 Jun 3. 
53. Chautard J, Alves A, Zalinski S, et al. Laparoscopic colorectal surgery in elderly patients: 
a matched case-control study in 178 patients. J Am Coll Surg. 2008 Feb;206(2):255-60. doi: 
10.1016/j.jamcollsurg.2007.06.316. Epub 2007 Sep 20. 
54. Person B, Cera SM, Sands DR, et al. Do elderly patients benefit from laparoscopic 
colorectal surgery? Surg Endosc. 2008 Feb;22(2):401-5. Epub 2007 May 24. 
55. Lian L, Kalady M, Geisler D, et al. Laparoscopic colectomy is safe and leads to a 
significantly shorter hospital stay for octogenarians. Surg Endosc. 2010 Aug;24(8):2039-43. 
doi: 10.1007/s00464-010-0900-x. Epub 2010 Feb 21. 
56. Keller SM, Markovitz LJ, Wilder JR, et al. Emergency and elective surgery in patients 
over age 70. Am J Surg. 1987 Nov;53(11): 636-40. 
57. Audisio RA, Pope D, Ramesh HS, et al. Shall we operate? Preoperative assessment in 
elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit 
Rev Oncol Hematol. 2008 Feb;65(2):156-63. Epub 2007 Dec 21. 
58. Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track 
surgery. Ann Surg. 2008 Aug;248(2):189-98. doi: 10.1097/SLA.0b013e31817f2c1a. 
59. Gouvas N, Tan E, Windsor A, et al. Fast-track vs. standard care in colorectal surgery: a 
meta-analysis update. Int J Colorectal Dis. 2009 Oct;24(10):1119-31. doi: 10.1007/s00384-
009-0703-5. Epub 2009 May 5. 
60. Bederman SS, Betsy M, Winiarsky R, et al. Postoperative ileus in the lower extremity 
arthroplasty patient. J Arthroplasty. 2001 Dec;16(8): 1066-70. 
129 
 
61. Davidson ED, Hersh T, Brinner RA, et al. The effects of metoclopramide on 
postoperative ileus: a randomized double-blind study. Ann Surg. 1979 Jul;190(1): 27-30. 
62. Longo WE, Vernava AM. Prokinetic agents for lower gastrointestinal motility disorders. 
Dis Colon Rectum. 1993 Jul;36(7): 696-708. 
63. Tollesson PO, Cassuto J, Rimback G, et al. Treatment of postoperative paralytic ileus 
with cisapride. Scand J Gastroenterol. 1991 May;26(5): 477-82. 
64. Kehlet H, Mogensen T. Hospital stay of 2 days after open sigmoidectomy with a 
multimodal rehabilitation program. Br J Surg. 1999 Feb;86(2): 227-30. 
65. Polle SW, Wind J, Fuhring JW, et al. Implementation of a fast-track peri-operative care 
program: what are the difficulties? Dig Surg. 2007;24(6):441-9. Epub 2007 Sep 13. 
66. Disbrow EA, Bennett HL, Owings JT. Effect of preoperative suggestion on postoperative 
gastrointestinal motility. West J Med. 1993 May;158(5): 488-92. 
67. Rao SS, Beaty J, Chamberlain M, et al. Effects of acute graded exercise on human 
colonic motility. Am J Physiol. 1999 May;276(5 Pt 1):G1221-6. 
68. Cheatham ML, Chapman WC, Key SP, et al. A meta-analysis of selective versus routine 
nasogastric decompression after elective laparotomy. Ann Surg. 1995 May;221(5):469-76; 
discussion 476-8. 
69. Baig MK, Wexner SD. Postoperative ileus: a review. Dis Colon Rectum. 2004 
Apr;47(4):516-26. Epub 2004 Feb 25. 
70. Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of peri-
operative fluid excess. Br J Anaesth. 2002 Oct;89(4): 622-32. 
71. Nisanevich V, Felsenstein I, Almogy G, et al. Effect of intraoperative fluid management 
on outcome after intraabdominal surgery. Anesthesiology. 2005 Jul;103(1): 25-32. 
130 
 
72. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid 
restriction on postoperative complications: comparison of two peri-operative fluid regimens: a 
randomized assessor-blinded multicenter trial. Ann Surg. 2003 Nov;238(5): 641-8. 
73. Holte K, Foss NB, Andersen J, et al. Liberal or restrictive fluid administration in fast-track 
colonic surgery: a randomized, double-blind study. Br J Anaesth. 2007 Oct;99(4):500-8. 
Epub 2007 Aug 6. 
74. Whelan RL, Franklin M, Holubar SD, et al. Postoperative cell mediated immune 
response is better preserved after laparoscopic vs. open colorectal resection in humans. 
Surg Endosc. 2003 Jun;17(6):972-8. Epub 2003 Mar 19. 
75. Hegarty N, Dasgupta P. Immunological aspects of minimally invasive ecologic surgery. 
Curr Opin Urol. 2008 Mar;18(2):129-33. doi: 10.1097/MOU.0b013e3282f517fc. 
76. Schwenk W, Haase O, Neudecker J, et al. Short term benefits for laparoscopic colorectal 
resection. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003145. 
77. Marks JH, Kawun UB, Hamdan W, et al. Redefining contraindications to laparoscopic 
colorectal resection for high-risk patients. Surg Endosc. 2008 Aug;22(8):1899-904. doi: 
10.1007/s00464-008-9828-9. Epub 2008 Mar 18. 
78. Demeure MJ, Fain MJ. The elderly surgical patient and postoperative delirium. J Am Coll 
Surg. 2006 Nov;203(5):752-7. Epub 2006 Sep 26. 
79. Gurlit S, Mollmann M. How to prevent peri-operative delirium in the elderly? Z Gerontol 
Geriatr. 2008 Dec;41(6):447-52. doi: 10.1007/s00391-008-0020-6. Epub 2008 Oct 30. 
80. Price CC, Garvan CW, Monk TG. Type and severity of cognitive decline in older adults 
after noncardiac surgery. Anesthesiology. 2008 Jan;108(1): 8-17. 
131 
 
81. Robinson TN, Raeburn CD, Tran ZV, et al. Postoperative delirium in the elderly: risk 
factors and outcomes. Ann Surg. 2009 Jan;249(1):173-8. doi: 
10.1097/SLA.0b013e31818e4776. 
82. Bryson GL, Wyand A. Evidence-based clinical update: general anesthesia and the risk of 
delirium and postoperative cognitive dysfunction. Can J Anaesth. 2006 Jul;53(7): 669-77. 
83. Story DA. Postoperative complications in elderly patients and their significance for long-
term prognosis. Curr Opin Anaesthesiol. 2008 Jun;21(3):375-9. doi: 
10.1097/ACO.0b013e3282f889f8. 
84. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 
2002 Jun;183(6): 630-41. 
85. Person B, Wexner SD. The management of postoperative ileus. Curr Prob Surg. 2006 
Jan;43(1): 12-65. 
86. McNicol ED, Boyce D, Schumann R, et al. Mu-opioid antagonists for opioid-induced 
bowel dysfunction. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006332. doi: 
10.1002/14651858.CD006332.pub2. 
87. FDA. FDA approves Entereg to help restore bowel function following surgery. 2008 
[online]. Available from URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce 
ments/2008/ucm116899.htm [Accessed 2009 May 13]. 
88. Entereg (alvimopan capsules): US prescribing information. Exton (PA): Adolor, 2008 
[online]. Available from URL: http://www.adolor.com/product/index.asp [Accessed 2010 Sep 
21]. 
89. Entereg: important safety information [online]. Available from URL: 
http://www.entereg.com/efficacy.html [Accessed 2009 May 13]. 
132 
 
90. Soffer EE, Adrian TE. Effect of meal composition and sham feeding on duodenojejunal 
motility in humans. Dig Dis Sci. 1992 Jul;37(7): 1009-14. 
91. Katschinski M, Dahmen G, Reinshagen M, et al. Cephalic stimulation of gastrointestinal 
secretory and motor responses in humans. Gastroenterology. 1992 Aug;103(2): 383-91. 
92. Noble EJ, Harris R, Hosie KB, et al. Gum chewing reduces postoperative ileus? A 
systematic review and meta-analysis. Int J Surg. 2009 Apr;7(2):100-5. doi: 
10.1016/j.ijsu.2009.01.006. Epub 2009 Jan 31. 
93. Asao T, Kuwano H, Nakamura J, et al. Gum chewing enhances early recovery from 
postoperative ileus after laparoscopic colectomy. J Am Coll Surg. 2002 Jul;195(1): 30-2. 
94. Gustafsson UO, Scott MJ, Schwenk W, et al.; Enhanced Recovery After Surgery 
Society. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery 
After Surgery (ERAS®) Society recommendations. Clin Nutr. 2012;31:783–800. 
95. Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut. 
2009;58:1300–1311. 
96. O’Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute 
kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104:868–
876. 
97. Klein M, Gögenur I, Rosenberg J. Postoperative use of nonsteroidal anti-inflammatory 
drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: 
cohort study based on prospective data. BMJ. 2012;345:e6166. 
98. Hakkarainen TW, Steele SR, Bastaworous A, et al. Nonsteroidal anti-inflammatory drugs 
and the risk for anastomotic failure: a report from Washington State’s Surgical Care and 
Outcomes Assessment Program (SCOAP). JAMA Surg. 2015;150:223–228. 
133 
 
99. Chapman SJ, Pericleous A, Downey C, Jayne DG. Postoperative ileus following major 
colorectal surgery. Br J Surg. 2018;105:797–810. 
100. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated 
peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats 
and humans.Endocrinology.2000;141:4255– 4261. 
101. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive 
gastrointestinal motility in humans.Gut.2006;55:327–333. 
102. Ankersen M, Kramer Nielsen K, Kruse Hansen T, Raun K, Sehested Hansen B. Growth 
hormone secretagogues derived from NN703 with hydrazidesas c-terminal.Eur J Med 
Chem.2000;35:487– 497. 
103. Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B. Prokinetic effects of 
a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus.Dig Dis 
Sci.2007;52:2241–2248. 
104. Fraser GL, Venkova K, Hoveyda HR, Thomas H, GreenwoodVan Meerveld B. Effect of 
the ghrelin receptor agonist TZP-101 on colonic transit in a rat model of postoperative 
ileus.Eur J Pharmacol.2009;604:132–137. 
105. Ejskjaer N, Vestergaard E, Hellstrom P, et al. Ghrelin agonist (TZP-101) accelerates 
gastric emptying in adults with diabetes and symptomatic gastroparesis: an exploratory, 
randomized, placebo-controlled, double-blind study. Aliment Pharm Ther.2009;29:1179–
1187. 
106. Popescu I, Fleshner PR, Pezzullo JC, et al. The Ghrelin agonist TZP-101 for 
management of postoperative ileus after partial colectomy: a randomized, dose-ranging, 
placebo-controlled clinical trial. Dis Colon Rectum. 2010 Feb;53(2):126-34. 
 
134 
 
Chapter 7: Closure of the ileostomy 
 
Overview 
      This chapter will broaden the understanding of the indications, clinical course and 
potential complication for temporary loop ileostomy after mid to low rectal cancer surgery 
and its reversal. The critical knowledge explained by the published data is essential in the 
comprehensive care of rectal cancer patients.  
 
Loop ileostomy Closure after Laparoscopic vs. Open 
Surgery: Is There a Difference?  
(Surg Endosc. 2013 ;27(1):90-4) 
BACKGROUND: Temporary loop ileostomy is commonly performed to protect the 
distal anastomosis during both open and laparoscopic colectomies. This study aimed 
to evaluate the impact of initial open and laparoscopic colorectal resection on the 
outcomes of ileostomy closure. METHODS: After institutional review board approval, 
all patients who underwent loop ileostomy closure from January 2008 to July 2012 
were identified. The patients’ demographics, diagnosis, American Society of 
Anesthesiology (ASA) classification, type of resection, approach (laparoscopic [LS] or 
open [OS] surgery), use of antiadhesion barrier, and ileostomy closure outcomes 
were obtained from a chart review. The outcomes of ileostomy closure after LS and 
OS colorectal resections were compared using Chi-square for categorical variables 
and Student’s t test for continuous variables. RESULTS: The study identified 351 
patients with a mean age of 51 years: 145 patients (41.2 %) in the LS group and 206 
patients (58.8 %) in the OS group. The most common procedures performed were total 
proctocolectomy with ileal J pouch anal anastomosis (109 patients: 49 LS, 60 OS) and 
restorative proctectomy (99 patients: 34 LS, 65 OS). At the time of ileostomy closure, 
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the patients in the LS group had a significantly shorter mean operative time (LS 60.9 
vs OS 82.6 min; p<0.001) and a shorter hospital stay (LS 4.9 vs OS 5.8 days; p=0.042). 
The overall complication rate was 20.1 % (70 patients), and the rate in the OS group 
was significantly higher (p=0.028). The most common complications were 
postoperative ileus (41 patients: 13 LS vs 28 OS) and enterocutaneous fistula (5 
patients, all in the OS group). CONCLUSIONS: Loop ileostomy closure after 
laparoscopic colorectal surgery is associated with a significantly shorter operative 
time and hospital stay as well as a lower rate of postoperative complications. Superior 
outcomes after loop ileostomy closure lend further support to the use of laparoscopy. 
      Temporary loop ileostomy is commonly performed in colorectal surgery to attenuate the 
potential adverse sequelae of anastomotic leakage (1–6) after construction of a distal pelvic 
anastomosis during both open and laparoscopic proctectomies. Subsequent reversal of loop 
ileostomy to restore bowel continuity and to improve patients’ quality of life generally is 
undertaken 12 weeks after the index surgery. 
      However, although loop ileostomy closure is a potentially simple and relatively safe 
procedure (7), it is not always completely innocuous. Besides dehydration and electrolyte 
abnormality secondary to high stomal output, the difficulty during creation and closure of 
loop ileostomy may lead to serious complications (8–10). A recent review of 26 studies by 
Kaidar-Person et al. (11) reported rates of small bowel obstruction (0–15 %), wound infection 
(0–18.3 %), anastomotic leak (0–8 %), and enterocutaneous fistula (0.5–7 %) resulting from 
ileostomy closure after both open and laparoscopic surgeries.  
      The technical difficulty during stoma closure is strongly related to the degree of adhesion 
formed around the ileostomy site. To date, no good evidence exists to demonstrate the 
differences in degree of adhesion formation after laparoscopic versus open colorectal 
surgery (12, 13). A recent report from the Conventional versus Laparoscopic Assisted 
Surgery in Colorectal Cancer (CLASICC) trial (14) on adhesion-induced intestinal obstruction 
136 
 
showed no differences between these two approaches. This study aimed to evaluate the 
impact of initial open and laparoscopic colorectal resection on the outcomes of ileostomy 
closure.  
 
Patients and methods  
      After institutional review board approval, all patients who had undergone loop ileostomy 
closure at Cleveland Clinic Florida between January 2008 and July 2010 were identified from 
a prospectively collected colorectal surgery database. The exclusion criteria for the study 
ruled out patients who had undergone reversal as part of multiple procedures and patients 
who had experienced intraabdominal complications after their initial surgeries. The patients’ 
demographics including age, gender, diagnosis, American Society of Anesthesiologists 
(ASA) classification, type of previous surgical procedure (laparoscopic [LS] or open [OS] 
surgery), use of anti-adhesion barrier (Seprafilm; Genzyme Corp., Cambridge, MA, USA), 
and ileostomy closure outcomes were obtained from a chart review.  
      For the patients who received an anti-adhesion barrier (Seprafilm), the barrier was 
applied under the midline incision and around the stoma. The perioperative outcomes of 
ileostomy closure after LS and OS colorectal resections were compared using Chi-square for 
categorical variables and Student’s t test for continuous variables. A p-value lower than 0.05 
was considered statistically significant. Postoperative ileus was defined as more than three 
episodes of emesis in 24 h and a return to nothing by mouth or to insertion of an nasogastric 
tube (15). Enterocutaneous fistula was defined as enteric drainage emanating from the 
incision wound without a sign of sepsis or generalized peritonitis (16). 
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Surgical technique 
      After radiographic and endoscopic confirmation of adequate anastomotic healing, all the 
patients were scheduled for loop ileostomy reversal. The choice of an open or laparoscopic 
approach and the use of Seprafilm at the index operation were at the preference of the 
surgeon. 
      A parastomal incision was performed, and the loop ileostomy was dissected from the 
surrounding subcutaneous tissues, rectus fascia, and peritoneum. Adequate length of small 
bowel was mobilized from intraabdominal adhesions. Wound extension was undertaken as 
necessary, and conversion to a midline incision was required if small bowel mobilization 
could not be achieved safely through the parastomal incision. Careful inspection together 
with betadine irrigation into each small bowel limb then was performed to assess for any 
possible seromuscular injuries. Standard stapled side-to-side bowel closure technique was 
used as previously described [17]. Absorbable subcuticular purse-string suture was 
performed, and loose betadinesoaked gauze packing was applied to the surgical site after 
fascial closure. Prophylactic antibiotics were continued for 24 h postoperatively. 
 
Statistical analysis 
      Statistical analyses were performed using Fisher’s exact test, a likelihood ratio Chi-
square test, or Student’s t test as appropriate. Allpvalues lower 0.05 were considered 
statistically significant. 
 
Results 
      The study identified 351 patients (160 males, 191 females) with a median age of 51 
years (range, 14–89 years): 145 (41.2 %) in the LS group and 206 (58.8 %) in the OS group. 
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The groups had comparable demographics as follows: median body mass index (BMI) (LS: 
24.4 kg/m2; range, 15.3–48.9 kg/m2 vs OS: 25.0 kg/m2; range, 14.1–96.5 kg/m2), ASA 
classification (91 % ASA 2), nature of diagnosis (malignant or benign), and number of 
patients who received preoperative radiotherapy (36 LS [81.8 %] vs 54                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
OS [84.3 %]). The time from the original surgery to the reversal of ileostomy was significantly 
longer in the OS group (18.1±8.4 weeks) than in the LS group (16.1± 4.6 weeks) (p=0.005). 
Table1 shows the demographic characteristics of the patients in both groups. 
      The most common procedures performed were restorative proctocolectomy with ileal J 
pouch anal anastomosis (109 patients [31 %]: 49 LS patients [33.8 %] vs 60 OS patients 
[29.1 %], nonsignificant difference) followed by restorative proctectomy with colonic J pouch 
anal anastomosis (99 patients [28 %]: 34 LS patients [23.4 %] vs 65 OS patients [31.6 %], 
nonsignificant difference). The two groups did not differ significantly in the use of an 
antiadhesion barrier (Seprafilm) around the ileostomy (4 LS vs 16 OS).  
      At the time of ileostomy closure, the patients in the LS group had a significantly shorter 
mean operative time (LS 60.9±22.1 vs OS 82.6±61.8 min; p<0.001) and hospital stay (LS 
4.9±3.8 vs OS 5.8±4.8 days; p=0.042). The intraoperative blood loss was minimal in all 
cases. 
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Table 1 Demographic data 
                                                                                       LS                                  OS                           p Value 
                                                                                   (n=145)                           (n=206) 
                                                                                     n(%)                                n(%) 
Median age: years (range)                                   50 (14–89)                       52 (16–85)                       0.064 
Gender                                                                                                                                                    0.110 
 Male                                                           60 (40)                           100 (48.5) 
 Female                                                       90 (60)                           106 (51.5) 
Median BMI: kg/m2                                                   24.4                                  25.0                              0.352 
     (range)                                                            (15.3–48.9)                        (14.1–96.5) 
ASA                                                                                                                                                         0.737 
 1                                                                10 (6.7)                                18 (8.7) 
 2                                                                138 (92)                           186 (90.3) 
 3                                                                 2 (1.3)                                  2 (1) 
 4                                                                     0                                          0  
Diagnosis                                                                                                                                                0.703 
 Benign                                                    101 (41.6)                          142 (57.3) 
 Malignant                                                 44 (40.7)                            64 (59.3) 
Preoperative radiotherapy                                    36 (81.8)                            54 (84.3)                         0.73 
Mean time to ileostomy                                         16.1±4.6                            18.1±8.4                         0.005 
reversal (weeks) 
LS laparoscopic surgery, OS open surgery, BMI body mass index, ASA, American Society of Anesthesiology 
 
Conversion to a midline incision was performed for one patient (0.7 %) in the LS group 
compared with five patients (2.4 %) in the OS group. Table 2lists the surgery-related 
information. 
      The overall complication rate was 20.1 % (70 patients), and the LS group had a lower 
complication rate (14.5 %) than the OS group (24.5 %) (p=0.028). The most common 
140 
 
complications were postoperative ileus (41 patients: 13 LS patients [9 %] vs 28 OS patients 
[13.6 %]), urinary  
 
Table 2 Operative outcomes 
                                                                       LS                                  OS                           p Value 
                                                                  (n=145)                          (n=206) 
                                                                     n(%)                              n(%) 
Procedure                                                                                                                             0.259 
 RPC/IPAA                                    49 (33.8)                          60 (29.1) 
 RP/CPAA                                     34 (23.4)                          65 (31.6) 
 Others                                         62 (42.8)                          81 (39.3) 
Mean operative time (min)                      60.9±22.1                         82.6±61.8                      <0.001 
Conversion to midline incision                  1(0.7)                              5(2.4)                           0.407 
Anti-adhesion barrier (Seprafilm)              4 (2.8)                           11 (7.6)                           0.063 
Mean hospital stay (days)                          4.9±3.8                          5.8±4.8                           0.042 
LS laparoscopic surgery, OS open surgery, RPC/IPAA restorative proctocolectomy with ileal J pouch 
anal anastomosis, RP/CPAA restorative proctectomy with colonic J pouch anal anastomosis 
 
 
retention (6 patients: 2 LS patients [1.4 %] vs 4 OS patients [1.9 %]), and enterocutaneous 
fistula (ECF) (5 patients [2.4 %], all in the OS group).  
      Two of the patients with ECF also had intraabdominal collections, which were 
successfully drained percutaneously under radiologic guidance. No isolated surgery site 
infection, postoperative adhesion-induced intestinal obstruction, or postoperative mortality 
was identified. All complications were treated conservatively without the need for surgical 
intervention. Table 3 lists the postoperative complications in both groups. 
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Discussion 
      Although closure of loop ileostomy may be considered a simple and minor procedure, it 
has been associated with a morbidity rate reaching 33 %, with a significant adverse impact 
on patient outcomes (18).  
 
Table 3 Complications 
                                                                       LS                                  OS                           p Value 
                                                                    (n=145)                           (n=206) 
                                                                      n(%)                               n(%) 
Overall complications                              21 (14.5)                           49 (24)                          0.028 
Postoperative ileus                                      13                                    28 
ECF                                                               0                                      5 
Wound dehiscence                                       0                                      1 
Urinary retention                                           2                                      4 
Pulmonary complications                             1                                      2 
Cardiac complications                                  1                                      0 
Others                                                            4                                      9 
LS laparoscopic surgery, OS open surgery, ECF enterocutaneous fistula 
 
 
The amount of adhesion formation around the ileostomy is associated with different degrees 
of technical difficulty. Extensive adhesiolysis may lead to a variety of intraoperative 
complications such as seromyotomy and enterotomy, as well as postoperative complications 
including ileus, obstruction, and fistula.  
      In the current study, the overall complication rate was 20.1 %, including surgical 
complications such as postop erative ileus (11.7 %), ECF (1.4 %), and wound dehiscence 
142 
 
(1.4 %). These findings are comparable with complication rates reported in the literature (8–
11). 
      Seprafilm is a sodium hyaluronate/carboxymethylcellulose absorbable barrier used to 
prevent adhesion formation in intraabdominal procedures. Salum et al. (19) reported 
interesting results from a multicenter trial comparing patients who received Seprafilm at the 
time of loop ileostomy construction with patients who did not. Seprafilm significantly 
decreased adhesion formation around the stoma but not operative time, intraoperative 
morbidities including myotomy and enterotomy, or postoperative complications. 
      Laparoscopic surgery may be associated with less adhesion formation than open 
surgery, but the results in the literature are contradictory. The current study showed a 
significantly shorter operative time for ileostomy closure in patients who underwent prior 
laparoscopic surgery compared with open procedures. This fact may reflect less difficulty 
with mobilization due to fewer and far less dense adhesions, leading to significantly fewer 
postoperative complications and a shorter hospital stay. The threefold greater chance of a 
midline conversion and the 2.4 % ECF rate found only in the open group also suggest 
increased technical difficulty and likely a higher degree of more dense adhesions among 
these patients. 
      A recent case-control study reported by Li, et al. (20) comparing the stoma-related 
morbidity between the ileostomy closure < 3 months post formation and > 3 months post 
formation. A total of 358 patients were analyzed (179 patients in each group). No difference 
was observed in estimated blood loss (EBL), operative time (OT) and length of stay (LOS) 
(all p > 0.05). Postoperative outcomes including wound infection, post-operative bleeding, 
intra-abdominal abscess, ileus, small bowel obstruction (SBO), anastomotic leak, 
reoperation, surgery related readmission, postoperative transfusion were also similar among 
the groups (p > 0.05). 
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      The omission of a temporary ileostomy is proposed to limit the need for hospital 
admission, avoid potential sphincter atrophy during the period of diversion, and avoid the 
complications of ileostomy closure. Additionally, in the case of ileal pouch surgery, a 
defunctioning ileostomy may theoretically compromise blood flow to the distal small bowel, 
thus increasing the risk of pouch ischemia (21). However, these potential benefits must be 
balanced with consequences of anastomosis leakage such as significant short- and long-
term morbidity, a reduced quality of life, poor subsequent bowel function, increased risk of 
cancer recurrence, and increased mortality (22–25). 
      A metaanalysis performed by Chow et al. (26) demonstrated that the consequences of 
stoma reversal often are underestimated. These authors also recommended that patients be 
selected carefully for defunctioning ileostomy and that they be counseled before the original 
surgery to spare the potential morbidity of stoma reversal. In addition to poor surgical 
technique with tension in the anastomosis (27), male gender, malnutrition, preoperative 
weight loss, cardiovascular disease, steroid use, preoperative vascular disease, 
preoperative alcohol abuse, perioperative blood transfusion, advanced age, obesity, 
previous radiation, and low anastomosis closer to the anus are known factors that may 
increase the risk of anastomosis leakage (5, 22, 28–34). 
      The limitation of this study was its retrospective design. As such, conversion to a midline 
incision and strict parameters for stoma-site incision enlargement were not analyzed. 
Similarly, no objective assessment of the extent or density of adhesions was undertaken. 
Furthermore, the choice of surgical access, open or laparoscopic, and the use of Seprafilm 
were at the discretion and preference of the surgeon. Despite these limitations, our results 
indicate that closure of loop ileostomy after open colectomy is technically more challenging 
than laparoscopic procedures secondary to adhesion formation. Surgeons should be aware 
of the significant existing morbidities associated with diverting ileostomy and provide 
appropriate patient counseling before the reversal, particularly after an open procedure. 
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Conclusion 
      Loop ileostomy closure after laparoscopic colorectal surgery is associated with a 
significantly shorter operative time and hospital stay, as well as with lower rates of 
postoperative complications than open surgery. Superior outcomes after loop ileostomy 
closure lend further support to the use of laparoscopy. 
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Chapter 8: Treatment of common stomal complication 
 
Overview 
      This chapter involves the proposed minimally invasive treatment for the most common 
stomal complication that can be diagnosed in low rectal cancer patient with extensive anal 
sphincters involvement and underwent abdominoperineal resection. This also includes other 
detail about the risk of developing parastomal hernia on each type of the stoma, and 
alternative procedure to overcome the complication.    
 
Laparoscopic Parastoma Hernia Repair, Multi-media 
Article.  
(Dis Colon Rectum 2010; 53(9):1334-6) 
Parastomal hernia is a common complication after stoma formation. Its reported 
incidence varies from 30% to 50%. Loop ileostomy has the lowest risk (0%– 6.2%), 
followed by end ileostomy, and loop colostomy with a similar risk of 28% to 30%. End 
colostomy carries the highest risk for parastomal hernia of 48%. Even though most 
hernias occur within the first 2 years after stoma construction, the risk of herniation 
extends up to 20 years. Theoretically, parastomal hernia occurs as a result of 
mechanical factors, an intrinsic defect in collagen metabolism, and wound repair. 
Parastomal hernia is asymptomatic most of the time, but it may be associated with 
serious complications such as strangulation and perforation; hence, elective repair is 
mandatory for carefully selected cases and surgical approaches. Primary closure of 
the aponeurosis at the hernia site, either via peristomal approach or through midline 
incision, is a simple procedure, but it carries a recurrence rate of 38% to 100%. Stoma 
relocation may result in a zero recurrence rate at the same hernia site, but the risk of a 
parastomal hernia after new stoma formation is still expected. In addition, an 
150 
 
incisional hernia at the previous colostomy site closure may also occur. Similar to 
other sites of hernia repair, prosthetic mesh has been used to reinforce the hernia 
defect intraperitoneally through open incision and recently via the laparoscopic 
approach. Mesh repair has demonstrated the lowest risk of recurrence for parastomal 
hernia of 0% to 33%. 
 
      Parastomal hernia is a common complication after stoma formation, with an incidence 
varying from 30% to 50% (1– 8). The risk depends on the type of stoma; loop ileostomy has 
the lowest risk (0%– 6.2%), followed by end ileostomy, loop colostomy (28%–30%), and end 
colostomy (48%) (2). Most parastomal hernias occur within the first 2 years after stoma 
construction, but the risk of herniation extends up to 20 years (9, 10). Etiological factors 
include mechanical stress, an intrinsic defect in collagen metabolism, and wound repair (2, 
11). Although parastomal hernias are mostly asymptomatic (3, 7), serious complications 
such as strangulation and perforation (2) may occasionally occur. Therefore, elective repair 
should be considered if the hernia is symptomatic, in particular, when there is an impending 
risk of complications occurring. Different surgical approaches for repair of parastomal 
hernias have been described. Direct primary closure of the aponeurosis at the hernia site via 
either peristomal or midline incision carries a reported recurrence rate of 38% to 100% (7). 
Stoma relocation does not remove the risk of parastomal hernia developing at the new 
stoma site, and incisional hernias may also develop at the previous stoma closure site. Other 
techniques have been explored because of these recurrences, which may be related to 
biological disease rather than simple mechanical rupture (12–14), as well as to the increased 
morbidity associated with recurrent repairs (15–17). In the repair of other types of hernia, 
prosthetic mesh has been used to reinforce the defect intraperitoneally (18–21); placed 
through an open incision, or more recently by a laparoscopic approach (22, 23). When mesh 
was used for repair of parastomal hernias with an open approach, a relatively low recurrence 
rate of 0% to 33% was reported (22). This dynamic article presents a novel technique in 
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which the parastomal hernia is repaired laparoscopically with the use of prosthetic mesh. A 
relatively large parastomal hernia is demonstrated to show the technique more clearly, but 
obviously this method can be applied effectively to the more common smaller parastomal 
hernias. 
 
Technique and Results  
      We have used this technique in 3 patients with parastomal hernias after 
abdominoperineal resection for anorectal cancer. Abdominoperineal resection had been 
performed with a lower midline incision in 1 patient and laparoscopically in the other 2, all 
after neoadjuvant chemoradiotherapy. These were 2 men with a median age of 75 (range, 
62– 83) years. All parastomal hernias were located on one side of the stoma. A PROCEED 
(laminated oxidized regenerated cellulose fabric and polypropylene; Ethicon, Livingston, 
Scotland, UK) mesh was trimmed to cover the defect with 5 cm of overlap (Fig.1). 
 
Figure 1 The parastomal hernia was measured. Mesh size was calculated.  
 A slit was made at one edge leading to a circle measured to fit around the stoma. The slit 
was aligned to cover the peritoneal surface where the stoma was attached, away from the 
parastomal hernia. After placement of the mesh, which included passing the slit around the 
colostomy so that the latter fitted into the cut circle (Fig. 2), the dome-shaped anterior 
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abdominal wall naturally allowed the edges of the mesh slit to overlap adequately for 
securing with laparoscopic tacks (Fig.3). These steps are shown in the video (see Video, 
Supplemental Digital Content 1, http://links. lww.com/DCR/A40).  
 
Figure 2 Mesh positioning using 2/0 Prolene brought out to the hernia apex. 
 
Figure 3 Laparoscopic tacks were used to secure the mesh to the abdominal wall.  
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Figure 4 Laparoscopic stitches were put to ensure the adequate repair of the hernia.  
 
Figure 5 The mesh was successfully placed 
 
The prolene stitch used to position the mesh for laparoscopic tacking actually anchored the 
center of the mesh to the apex of the hernia defect and, when tied in, helped in securing the 
position of the mesh (Fig. 4). The small skin incision overlying the knot was closed with an 
absorbable suture (Fig. 5). The median operating time was 43 (range, 32– 60) minutes and 
blood loss was 50 (range, 30– 70) mL. All of the patients tolerated a full diet on the 2nd 
postoperative day and were discharged 1 day later with minimal analgesic requirements. At 
a median 12 (range, 8–16) months follow-up, none of the patients had any complications, 
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stoma application problems, or recurrences (Fig. 6). In particular, the skin redundancy over 
the mesh repair seen in the demonstration was asymptomatic, did not affect stoma 
management, and had improved further at the latest follow-up. 
 
Figure 6 At 6 months’ follow-up after laparoscopic parastomal hernia repair. 
 
Discussion 
      A laparoscopic prosthetic mesh parastomal hernia repair technique was presented. The 
advantages of the laparoscopic method for mesh repair of nonparastomal ventral hernias 
include reduced analgesic requirements, reduced length of hospital stay, minimized 
abdominal wall trauma, and more rapid recovery. Decreased rates of wound and mesh 
infections have been reported previously (24). Uniquely for parastomal hernias, an important 
theoretical consideration, as addressed by our techniques, would be to avoid an incision 
close to the stoma where bowel contents could potentially seep through the wound onto the 
underlying mesh with predictably disastrous results. Some controversy has arisen from the 
available experience in open parastomal hernia mesh repair (25–28). A slit prosthetic mesh 
to accommodate the bowel exiting at the stoma has been reported to fail with the slit 
widening over time (25). A nonslit prosthetic mesh technique has been described where the 
bowel wall is first secured against the lateral abdominal wall and the mesh is then placed to 
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cover the remaining defect (26). In our technique, the laparoscopic tacking of the 
overlapping slit edges, which were also placed away from the hernia site, would potentially 
address this issue. Separation between the stoma and the surrounding key hole prosthesis 
is another cause of concern for recurrence. We placed intracorporeal sutures to attach the 
mesh to the bowel serosa to address this possible problem (27). Although nonabsorbable 
prosthetic mesh such as polypropylene has been reported to result in pain, obstruction, and 
erosion (28), this has not occurred in any of our patients, possibly because our technique 
tailored the size of the mesh aperture to provide a correct fit around the stoma. 
      To prevent mesh-related complications, such as fistula formation, adhesions, septic 
complications, and seroma formation, optimal mesh selection should be considered (28). For 
the intraperitoneal onlay mesh technique, the mesh surface facing the abdominal wall should 
be nonabsorbable material, inducing tissue response and allowing for integration of the 
mesh within the abdominal wall. The mesh surface facing abdominal contents also should be 
nonreactive material, causing a low or negligible inflammatory response, so that adhesions 
and subsequent erosion, septic complications, and fistulas do not develop (29). 
 
 
 
Conclusion 
      The advantages of laparoscopic surgery can be applied to parastomal hernia repair with 
encouraging early results (27). We demonstrated a method using mesh to address the 
various technical issues involved. It would be appropriate to consider randomized controlled 
trials with long-term follow-up to assess the optimal surgical management of parastomal 
hernias. 
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Chapter 9: Conclusion, outcomes and future research 
directions   
 
      Total mesorectal excision (TME) (1) has brought the revolution and the improvement of 
outcomes measured in both oncologic and functional outcomes that includes bowel, urinary, 
and sexual function. It has developed to become a standard procedure for rectal cancer 
surgery. However, to achieve a complete TME specimen, surgeons around the world have 
searched and studied to find the optimal tools and/or techniques to overcome the challenge 
in difficult dissection along the natural curve of human pelvis.  
      Laparoscopy in the management of rectal cancer has gained popularity. Multiple 
randomized trials (2, 3) have shown the equivalent in short-term outcomes and perioperative 
morbidity and mortality of laparoscopic proctectomy as compared to open surgery. Long-
term oncologic outcomes also reported to be comparable between laparoscopic rectal 
cancer surgery and conventional open surgery (3-5). However, laparoscopic rectal cancer 
surgery remained a challenge with higher conversion rates (6). Technical challenge of poor 
ergonomic, coning and fulcrum effect was reported as the limitations of the procedure. 
Proctectomy can be even more difficult to work in the deep pelvis with in-line rigid 
instruments from angles that require complicated maneuvers to reach the extremes of the 
pelvis. On the other hand, 2 recent randomized trials failed to demonstrate noninferiority of 
laparoscopic rectal surgery to open surgery for oncologically successful resection in regard 
to circumferential and distal resection margins and total mesorectal excision (TME) 
completeness (7, 8). It is possible that modification of instruments or a different platform 
such as robotics will improve efficacy of minimally invasive techniques (8). Several authors 
(9-11) reported 3D high definition vision, wrist-like movement of  instruments  (endowristTM ),  
stable  camera  holding, motion  filter  for  tremor-free  surgery  and  improved ergonomics 
as major improvements in rectal surgery. Robotic rectal cancer surgery has been reported to 
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be feasible, safe and providing short-term outcomes comparable to conventional 
laparoscopic surgery (12, 13). Robotic surgery for rectal cancer is expected to have 
superiority in terms of oncologic and functional aspects theoretically because of the potential 
for meticulous TME dissection and nerve preservation (14, 15). Kim J., et al. recently 
demonstrated comparable long-term survival to laparoscopic TME. In addition, the authors 
also showed that robotic rectal surgery was a good prognostic factor for overall survival and 
cancer-specific survival, suggesting potential oncologic benefits. However, it seems that 
these expensive technological benefits have not reflected superiority in clinical outcomes. 
The preliminary results of an ongoing randomized control trial; “Robotic vs. Laparoscopic 
Resection for Rectal Cancer: The ROLARR Trial”, presented by Pigazzi A. at the American 
Society of Colon and Rectal Surgeons, Annual Meeting in 2015 including 471 rectal cancer 
patients (237 patients; robotic surgery, 234 patients; laparoscopic surgery) from 29 hospitals 
in 10 countries. The results showed no statistically significant advantages to robotic TME 
regarding to number of nodes, quality of TME specimens, involvement of circumferential 
margins and 30 day morbidity. The study also failed to demonstrate any statistically 
significant advantage relative to conversion rate (8.15%; robotic group, 12.2%; laparoscopic 
group). A similar short term oncologic outcome for both robotic group and laparoscopic 
group was also reported. 
      We introduced laparoscopic pull-through with coloanal anastomosis approach (the 
published manuscript in chapter 3) to facilitate mobilization of the most distal rectum and to 
overcome the inherent shortcomings of laparoscopic TME (16). As described clearly in 
chapter 3, the short-term perioperative outcomes and the quality of the specimens from 
laparoscopic pull-through with coloanal anastomosis was at least comparable to those who 
underwent laparoscopic low anterior resection. However, transanal dissection during 
laparoscopic pull-through with coloanal anastomosis allowed a better visualization for 
surgeons to complete sharp TME transanally. The study concluded that transanal dissection 
became very useful when the pelvis was narrow and when the rectal cancer was very distal. 
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In order to make a complete conclusion of the thesis which emphasized mainly on our 
proposed procedure, the data of long-term oncological outcomes from the same group of 
patients (unpublished data) is presenting below. 
     Thirty patients were enrolled in laparoscopic pull-through with coloanal anastomosis 
(LPT) group while 147 patients were enrolled in laparoscopic low anterior resection (LAR) 
group (Table 1). Approximately a third of the patients in both groups received neoadjuvant 
chemoradiotherapy. Low rectal tumor was found significantly more in laparoscopic pull-
through with coloanal anastomosis group (73%; LPT, 49%; LAR, p=0.149). The median 
tumor diameter was 4 cm. in both groups. Operative time was significantly longer in 
laparoscopic pull-through with coloanal anastomosis group (164.8 mins; LPT, 130.4; LAR, 
p<0.0001) (table 2). Comparable intraoperative blood loss, conversion rates, quality of the 
specimens including; the quality of TME, distal resected margin and circumferential margin 
positivity and perioperative short-term outcomes including; time to return to bowel function 
and hospital stays were demonstrated.    
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Table1 Demographic Data 
                                                                    LPT                       LAR                      P-value 
                                                                  (n=30)                   (n=147)  
                                                                   n (%)                      n (%) 
Neoadjuvant Chemoradiotherapy          9 (31.0%)            61 (43.3%)                0.2230 
Tumor site                                                                                                           0.0149* 
 Mid rectum                              8 (26.7%)             75 (51.0%) 
 Low rectum                           22 (73.3%)             72 (49.0%) 
Tumor size (median, cm.)                             4                           4                        0.2649          
LPT laparoscopic pull-through procedure, LAR laparoscopic low anterior resection, * statistically significant 
 
Table 2 Operative outcomes 
                                                                   LPT                       LAR                      P-value 
                                                                   (n=30)                  (n=147)  
                                                                   n (%)                      n (%) 
Operative time (mins)                             164.8                      130.4                  <0.0001* 
Blood loss (mL)                                        96.4                        70.9                    0.3569 
Conversion                                             3 (10.0%)             12 (8.2%)                0.7221 
Complete mesorectum                           9 (50.0%)            66 (76.7%)               0.0608     
Distal resection margin (cm)                      2.9                          4.4                     0.0920 
Positive CRM                                          1 (3.3%)                 4 (3.6%)                0.3569 
Return to bowel function (days)                 4.9                          4.5                     0.5746 
Hospital stay (days)                                  11.3                          7.7                    0.0726  
LPT laparoscopic pull-through procedure, LAR laparoscopic low anterior resection, * statistically significant, CRM 
circumferential margin 
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Table 3 long-term outcomes  
                                                                                               LPT                       LAR                      P-value 
                                                                                             (n=30)                   (n=147)  
                                                                                               n (%)                      n (%) 
Follow-up time (months)                                46.4                   37.4                  0.5610 
Overall survival                                                       75.0%                89.1%                0.0627 
Local recurrence                                                   1 (3.3%)             1 (0.7%)              0.3127 
Systemic recurrence                                             5 (16.7%)         17 (11.6%)           0.5427 
LPT laparoscopic pull-through procedure, LAR laparoscopic low anterior resection, * statistically significant 
     
           The patients were followed for 46.4 months in laparoscopic pull-through with coloanal 
anastomosis group and 37.4 months in laparoscopic low anterior resection group. No 
significant different in overall survival was found among both groups. The comparable local 
recurrence and systemic recurrence was also demonstrated.      
      Several surgical platforms and techniques have been reported and claimed to be the 
treatment of choice for rectal cancer patients. The key toward a successful treatment for this 
particular group of patients needs to be tailored by well-trained and highly experienced group 
of multidisciplinary team (MDT) specialists. It has become increasingly clear that some 
patients belong to a particularly high-risk group, and a one-size-fits-all strategy is not 
optimal. The approach of the surgeon, radiologist, medical oncologist and pathologist is 
essential to maximize the potential for success in the management of rectal cancer, 
especially in locally advanced disease. Preoperative imaging study using high-quality pelvic 
MRI, recommended by the MURCURY study group (17-19), should currently be the gold 
standard to provide relevant details on rectal cancer characteristics. MDT should be carefully 
decide which patients would be beneficial for neoadjuvant treatment (20) rather than only a 
good-quality TME. The best possible outcomes will eventually be focused on the 
combination of careful preoperative staging, the appropriate application of neoadjuvant 
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treatment, less intraoperative and perioperative complications, sphincter-saving technique, 
rapid recovery, good short and long term oncological outcomes, acceptable functional 
outcomes and excellent patient satisfaction.  
      To become a reasonably well-trained academic colorectal surgeon who is competent to 
provide a standard of care for rectal cancer patients, I strongly believe that the individual 
requires standard training background, an adequate number of patients, continuous 
educations and the ability to conduct scientific methodology to find answers for relevant 
clinical challenge. The thesis intentionally combined chapters that some of them contained 
original ideas to solve the critical thinking and some of them were set as a review of the up-
to-date specific knowledge. The combination of all the presented chapters certainly added 
up the more understanding of the important points and answers to improve rectal cancer 
patient care.  
      Not only the surgeons who will continue to develop and conduct reliable surgical 
techniques and clinical studies to overcome the challenges in rectal cancer surgery. 
PROSPECT Trial’s (21) been currently enrolling rectal cancer patients to provide the data on 
the effectiveness of neoadjuvant chemotherapy versus the standard neoadjuvant 
chemoradiation. On the other hand, the scientists also continue to study and try to 
understand more in the molecular level aiming to find the predictive and prognostic 
molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer which 
perhaps will be the key to the success in the future treatment (22).  
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